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Ubiquitin-mediated proteolytic degradation is fundamental to eukaryotic cell 
cycle progression.  From late mitosis through early G1, the Anaphase Promoting 
Complex (APC) is essential for cell-cycle relevant proteolytic degradation, and its 
activity is targeted to appropriate substrates by the evolutionarily conserved coactivators 
Cdc20 and Cdh1.  After an initial wave of APC-Cdc20 activity, APC-Cdh1 degrades 
multiple mitotic proteins from mitotic exit through G1; inhibitory phosphorylation of 
Cdh1 by CDK and Polo kinase may allow accumulation of Cdh1 targets in the 
subsequent cell cycle.  I demonstrate lethality of exact endogenous gene replacement of 
CDH1 with the CDK-unphosphorylatable CDH1-m11 allele; neither polo kinase sites nor 
polo interaction motifs are required for Cdh1 regulation.  CDH1-m11 cells arrest in the 
first cycle with replicated DNA;~30% of these cells have bipolar spindles. Construction 
of bipolar spindles in these cells is strikingly sensitive to gene dosage of the 
stoichiometric Cdh1 inhibitor ACM1.  CDH1-m11 cells with bipolar spindles fail to 
progress to anaphase, suggesting that Cdh1 inhibits multiple spindle-regulatory pathways. 
Expression of undegradable mitotic cyclin causes spindle pole body separation (a key 
step in bipolar spindle assembly) in CDH1-m11 cells; thus mitotic cyclins are a 
significant target for Cdh1 with respect to bipolar spindle assembly, and reciprocally, 
cyclin-Cdk activity is the most significant mechanism for Cdh1 inactivation.   
Cdc20 has been proposed to be a Cdh1 target, but regulation of Cdc20 proteolysis 
has been controversial.  My experiments demonstrate that degradation of Cdc20 can be 
dependent on Cdh1 and Cdc20 destruction boxes, but Cdh1- and db-independent modes 
of Cdc20 proteolysis are also effective in limiting Cdc20 levels.   
To better understand the mechanisms by which multisite CDK phosphorylation 
inhibits Cdh1, I employed a novel recombination approach to create a series of partially 
unphosphorylatable CDH1 alleles ablating contiguous sites beginning at either the N or C 
terminus.  Strains lacking N-terminal phosphorylation sites were strictly dependent upon 
ACM1 and S-phase cyclins for viability, and a fraction of cells displayed evidence of 
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Oscillations in CDK activity drive the cell cycle 
The oscillation of cyclin dependent kinase (CDK) activity lies at the heart of the 
cell cycle, serving to coordinate the events of the cell cycle in a temporally appropriate 
manner.  CDK activity is dependent upon CDK binding to a partner cyclin (Draetta et al., 
1989); canonical cyclins are synthesized and destroyed in each cell cycle (Evans et al., 
1983).  This oscillation in CDK activity serves to coordinate budding, DNA replication, 
spindle pole body (SPB) duplication and separation, mitotic spindle assembly, mitotic 
entry, DNA segregation, mitotic spindle disassembly, mitotic exit, and cytokinesis such 
that each occurs once and only once during a cell cycle (Stern and Nurse, 1996).  
Specifically, the cell cycle begins at a low CDK state, during which DNA replication 
origins can be efficiently loaded.  The transcriptional induction of G1 cyclins then allows 
for polarized growth, budding and progression through G1 (Cross and Tinkelenberg, 
1991; Dirick and Nasmyth, 1991; Richardson et al., 1989; Skotheim et al., 2008).  The 
G1 cyclins, which are unstable proteins whose levels fall rapidly after transcriptional 
shutoff (Schneider et al., 1998), activate expression and activity of the B-type cyclins 
Clb5 and Clb6 which are required for replication origin firing and efficient DNA 
replication (Epstein and Cross, 1992; Schwob and Nasmyth, 1993).  These are temporally 
followed by the remaining B-type cyclins which promote mitotic entry, the shutoff of G1 
cyclin transcription, and the switch to isotropic growth (Amon et al., 1993).  To exit from 
mitosis, the CDK activity of the mitotic B-type cyclins must be reduced; this occurs 
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largely by cyclin destruction.  The cell cycle thus progresses by alternating between a 
CDK-driven phase and a destruction driven phase (Figure 1.1).  The resultant low CDK 
state must be maintained to allow for proper loading of replication origins and the 
subsequent transcriptional induction of G1 cyclins so as to start the cell cycle anew 
(Wäsch and Cross, 2002).   
 
The anaphase-promoting complex (APC)  is a ubiquitin ligase responsible for the 
destruction of cyclins 
The APC is in large part responsible for cyclin degradation at the end of mitosis: 
the cell cycle ends in highly efficient and specific protein destruction orchestrated by the 
APC, which mediates the sequential degradation of cyclins and other relevant cell cycle 
proteins and machinery (King et al., 1995; Sudakin et al., 1995).   
The APC is a large ubiquitin E3 ligase comprised of at least 13 proteins, and 
functions in coordination with two homologous mitotic coactivators, Cdc20p and Cdh1 
(Schwab et al., 1997; Thornton et al., 2006; Visintin et al., 1997; Yoon et al., 2002; 
Zachariae et al., 1998b).  The APC and both coactivators are conserved throughout 
eukaryotic evolution.  The core APC catalyzes the transfer of ubiquitin from ubiquitin 
conjugating enzymes (E2s) to substrates, thus marking them for proteasomal destruction 
(Figure 1.2) (Gmachl et al., 2000; Leverson et al., 2000). The APC utilizes two E2s 
sequentially to ubiquitinate substrates: Ubc4 attaches a single ubiquitin which is then 











Figure 1.1 Cell cycle progression entails alternating CDK-driven and destruction driven 
phases.  B-type cyclins drive DNA replication and mitotic entry.  Onset of a destructive 
















Figure 1.2 The APC ubiquitinates substrates to target them for proteasomal destruction.  
The APC, in coordination with one of two mitotic activators—Cdc20 and Cdh1—is 
responsible for the processive transfer of ubiquitin to substrates.  The proteasome 
degrades substrates that have been marked with a polyubiquitin chain.   
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APC is activated by two temporally separated coactivators, Cdc20 and Cdh1 
 
The APC is active only from anaphase onset through the subsequent G1, although 
the core complex is present throughout the cell cycle.  The conserved coactivators Cdc20 
and Cdh1 provide regulation of timing and specificity.  APC-Cdc20 begins B-type cyclin 
degradation and APC-Cdh1 continues it through mitosis and into the ensuing G1 (Irniger 
and Nasmyth, 1997; Schwab et al., 1997; Shirayama et al., 1999; Wäsch and Cross, 2002; 
Yeong et al., 2000; Zachariae et al., 1998a). 
A major basis for this difference in timing is differential regulation of APC-Cdc20 
and APC-Cdh1 by cyclin-CDK activity.  APC-Cdc20 is active at high CDK levels, with 
Cdc20 binding preferentially to CDK-phosphorylated APC (Kramer et al., 2000; Rudner 
and Murray, 2000).  Cdc20 itself is an unstable protein, accumulating late in the cell 
cycle, followed by mitotic degradation (Prinz et al., 1998; Shirayama et al., 1998; 
Weinstein, 1997).  As B-type cyclin levels decline and the Cdc14 phosphatase (at least in 
budding yeast) is released from a nucleolar sequestration, the balance between CDK 
activity and phosphatase activity shifts such that Cdh1 is dephosphorylated on at least 
some of its 11 CDK sites, which collectively serve to inhibit Cdh1 function (Zachariae et 
al., 1998a).  The second wave of APC-mediated degradation then ensues, dependent on 
dephosphorylated Cdh1.  This activity is responsible for continued mitotic cyclin 
degradation through G1, until Cdh1 inactivation in the succeeding cell cycle (Amon et 
al., 1994). 
In addition to these temporal differences, Cdc20 and Cdh1 likely have 
intrinsically different substrate specificities, although they both contribute to mitotic 
cyclin degradation (Figure 1.3).  Cdc20 promotes Pds1 proteolysis, an anaphase inhibitor 
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that prevents cleavage of cohesin, the protein keeping sister chromatids attached (Cohen-
Fix et al., 1996; Shirayama et al., 1999).  APC-Cdh1 seems ineffective at promoting Pds1 
degradation, but promotes degradation of several spindle proteins and perhaps Cdc20 
itself (Hildebrandt and Hoyt, 2001; Huang et al., 2001; Juang et al., 1997; Schwab et al., 
1997; Shirayama et al., 1998; Woodbury and Morgan, 2007; Zachariae et al., 1998a).  
This ordering is logical: the earlier APC-Cdc20 wave will promote anaphase and initial 
mitotic cyclin proteolysis, promoting APC-Cdh1 activation; APC-Cdh1 then completes 
mitotic cyclin proteolysis, allowing cytokinesis and other events of mitotic exit, removes 
Cdc20 to reset the system to G1, and contributes to spindle disassembly by proteolysis of 
spindle components.  This ordering could help ensure that anaphase precedes cytokinesis 
and spindle disassembly. 
 
Consequences of deleting APC coactivators and core subunits 
 CDC20 is essential for cell viability, and its absence results in an arrest with 
unseparated sister chromatids and high Clb2 levels (Sethi et al., 1991; Shirayama et al., 
1998).  Deletion of the APC-Cdc20 target PDS1 (securin) allows cdc20 cells to undergo 
anaphase (Sethi et al., 1991; Shirayama et al., 1998).  Further deletion of CLB5 results in 
a viable cdc20 pds1 clb5 triple mutant, capable of carrying out all essential cell-cycle 
functions (Shirayama et al., 1999).  This defines two critical targets of Cdc20; 
consistently, both have been reported to be poor APC-Cdh1 substrates (Schwab et al., 
1997; Visintin et al., 1997).  
 6
 
Figure 1.3 The APC is responsible for the destruction of B-type cyclins as well as 
spindle regulatory proteins  A APC-Cdc20 targets the S-phase cyclin Clb5 for 
destruction, and APC-Cdh1 targets the major mitotic cyclin Clb2.  APC-Cdh1 is also 
believed to target the remaining mitotic cyclins—Clb1, 3, 4—as well.  B APC-Cdc20 
targets the anaphase inhibitor Pds1 for degradation, resulting in the onset of anaphase.  
After spindle elongation, APC-Cdh1 is responsible for degradation of spindle motor 
proteins such as Cin8, which provide the motor activity for spindle elongation, and 
spindle stabilizing factors including Fin1.  Thus Cdc20 drives the onset of anaphase, and 
subsequent Cdh1 activity contributes to spindle disassembly after separation of sister 
chromatids to opposite poles. 
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In contrast to Cdc20, Cdh1 is not an essential protein.  cdh1 cells exhibit a 
moderate growth defect, a slight delay in disassembling elongated spindles, and retain 
Clb2 throughout the cell cycle (Schwab et al., 1997).   In G1, Cdh1 activity is partially 
redundant with Sic1 and the N-terminal region of Cdc6, which both effectively inhibit 
Clb activity as stoichiometric inhibitors: cells lacking Cdh1, Sic1 and the N-terminal 
region of Cdc6 are not viable, highlighting the essential role of inhibiting Clb activity in 
G1(Archambault et al., 2003).  However, there is no clearly redundant protein involved in 
Cdh1’s role in spindle disassembly and targeting structural substrates, making the 
viability of cdh1 strains somewhat unexpected.   
Remarkably, none of the APC targets need be degraded at all, if an effective 
means to regulate Clb activity is present: apc-null clb5 pds1 10XSIC1 strains 
(overexpressing the Sic1 Clb inhibitor) are viable (Thornton and Toczyski, 2003).  Thus 
the entire cell cycle can be run without any APC-mediated proteolysis.   
 
APC-Cdh1 and mitotic kinases 
Cdh1 was initially cloned as a high copy suppressor of cdc20-1 at the restrictive 
temperature.  In the absence of Cdh1, the mitotic cyclin Clb2 is present throughout the 
cell cycle (Schwab et al., 1997).  Cdh1 overexpression resulted in an arrest with 2C DNA 
content and hyperpolarized buds, and with persistence of the S-phase cyclin Clb5 
(Schwab et al., 1997).  Drosophila fizzy-related (a Cdh1 homolog) is responsible for 
clearing mitotic cyclins.  Fzr overexpression inhibits mitosis and results in DNA 
endoreduplication (Sigrist and Lehner, 1997).  Thus APC-Cdh1 may specifically 
proteolyze mitotic cyclins rather than S-phase cyclins.  Consistent with this, in addition to 
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Clb2, Cdh1 also targets the mitotic cyclin Clb3 (Irniger and Nasmyth, 1997; Zachariae et 
al., 1998a), and presumably Clb1 and Clb4 (close Clb2 and Clb3 homologs).  Clb1,2,3,4 
constitute all of the budding yeast mitotic cyclins. 
Cdh1 is also responsible for the destruction of Cdc5 (Shirayama et al., 1998), the 
yeast Polo-like kinase involved in mitotic exit and cytokinesis.  Cdc5 localizes to the 
spindle pole bodies (SPBs) and the mother bud neck, and overexpression results in 
hyperpolarized buds with multiple septin rings along these buds, and possible SPB over-
production (Song et al., 2000).  Cdc5 is probably not essential for any processes prior to 
anaphase, since Cdc5 inactivation results in a late anaphase arrest in temperature 
sensitive and engineered drug sensitive cdc5 alleles, as well as by transcriptional shut-off 
(Hartwell et al., 1973; Snead et al., 2007; Song and Lee, 2001).  Cdc5 has been 
implicated in activation of the APC (Charles et al., 1998), but also in inactivation of 
APC-Cdh1 (Crasta et al., 2008). 
 
APC-Cdh1 and the mitotic spindle 
 Cdh1 has been implicated in degrading the spindle-regulatory proteins Ase1, 
Cin8, Cik1, Fin1 and possibly Kip1 (Benanti et al., 2009; Gordon and Roof, 2001; 
Hildebrandt and Hoyt, 2001; Juang et al., 1997; van Hemert et al., 2003).  Cin8 and Kip1 
are plus end kinesins, involved in keeping spindle poles separated (their deletion results 
in spindle pole bodies coming into approximation with one another) (Hoyt et al., 1992).  
Ase1 is a spindle midzone protein, involved in spindle stabilization and elongation 
(Schuyler et al., 2003).  Fin1 is an intermediate-filament-like protein that creates 
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filaments in between the two SPBs (van Hemert et al., 2003), and Cik1 associates with 
the kinesin Kar3 to regulate the mitotic spindle (Benanti et al., 2009). 
Overexpression of unphosphorylated Cdh1 blocks construction of a bipolar 
mitotic spindle (Crasta et al., 2008).  Mitotic spindle construction requires duplication of 
SPBs (functionally equivalent to metazoan centrosomes), followed by disassembly of the 
half-bridge connecting them and separation to opposite poles of the nucleus (Figure 
1.4A).  Subsequently, sister chromatid separation and anaphase spindle elongation 
separates chromosomes into the progeny (See Figure 1.4B, C).  The spindle is then 
disassembled; each cell inherits a single SPB, which starts the cycle anew.  Despite the 
dependence of destruction of many spindle proteins on Cdh1, spindle disassembly is 
delayed but not blocked by cdh1 deletion (Visintin et al., 1997); this delay may decrease 
fidelity of chromosome segregation (Ross and Cohen-Fix, 2003).  Expression of Cdh1-
resistant Ase1 results in  roughly a ten minute delay in spindle disassembly, comparable 
to that of cdh1 cells (Juang et al., 1997; Visintin et al., 1997).   
A proposed explanation for the failure of CDH1-overexpressing cells to construct 
a bipolar spindle lies in the fact that the plus end kinesins Cin8, and possibly Kip1, are 
Cdh1 targets (Crasta et al., 2006; Gordon and Roof, 2001; Hildebrandt and Hoyt, 2001).  
cin8 mutants display chromosomal instability and spindle defects, and cin8 kip1 strains 
are inviable (Hoyt et al., 1992).  Cin8 and Kip1 are implicated in SPB separation, as 
strain with both kip1 and the temperature sensitive allele cin8-3 retain a half-bridge at the 
restrictive temperature (Hoyt et al., 1992).   Mutations in the minus-end directed kinesin 
Kar3, which opposes the forces generated by Cin8 and Kip1, allow for separation of 
spindle pole bodies in the absence of Cin8 and Kip3 (Saunders and Hoyt, 1992).   
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Figure 1.4 Construction and regulation of the mitotic spindle.  A Bipolar spindle 
construction requires initial SPB duplication, followed by SPB separation.  B Schematic 
structure of the short bipolar spindle:  Interpolar microtubules, via motor proteins, push 
the SPBs apart from one another.  Each SPB emanates a kinetochore microtubule to one 
sister chromatids of each pair, pulling each sister chromatid poleward.  The two sister 
chromatids are attached to each other by cohesin; cohesin cleavage results in the 
poleward movement of chromatids.  C  Schematic of pathway regulating anaphase onset.  
Cdc20 activation results in Pds1 (securin) degradation, freeing the enzyme Esp1 
(separase) to cleave Scc1 (a major cohesin subunit), which allows for the poleward 
movement of chromosomes.   
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Additionally, overexpression of Cin8 is sufficient to separate SPBs in the presence of 
overexpressed unregulated Cdh1 (Crasta et al., 2006), suggesting that the aberrant 
degradation of these proteins may account for the ability of unregulated Cdh1 to block 
spindle formation.   
 
Dynamic Cooperation between CDK and APC-Cdh1 activity 
APC-Cdh1 targets both mitotic cyclins and spindle structural components for 
destruction more or less simultaneously.  Additionally, the phosphatase Cdc14, which 
dephosphorylates CDK targets, is released when Cdh1 is active, and Cdc14 likely 
contributes directly to Cdh1 activation via Cdh1 dephosphorylation (Visintin et al., 
1998).  The net result is that dephosphorylation and the degradation of some APC-Cdh1 
substrates are temporally coupled.  Fin1 is a well characterized example of this, wherein 
CDK phosphorylates Fin1 and inhibits its localization to the spindle (Woodbury and 
Morgan, 2007).  Dephosphorylation of Fin1 in anaphase targets it to the spindle, where it 
acts to stabilize the anaphase spindle, and where it is then degraded by APC-Cdh1 during 
spindle disassembly (Woodbury and Morgan, 2007).  CDK phosphorylation has been 
shown to prevent the association and function of other Cdh1 targets at the spindle 
midzone (Khmelinskii et al., 2009), so this coordinated regulation may be a general 
phenomenon.   
 
Substrate Targeting 
 Specific motifs in substrate proteins target them for APC-mediated ubiquitination: 
the  destruction box (consensus RxxL) (King et al., 1996), recognized by Cdc20 and 
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Cdh1; the KEN box, which may be more specific for Cdh1 (Pfleger et al., 2001) (but see 
Burton and Solomon, 2001), and the CRY box Cdh1 recognition sequence (Reis et al., 
2006).  Thus Cdh1 recognizes unique motifs that Cdc20 does not; in contrast, there are no 
known Cdc20-specific targeting sequences, although Cdc20 specific substrates exist.   
APC targeting mechanisms remain unclear.  The core APC has been reported to 
directly engage the destruction box (Yamano et al., 2004).  Alternatively, the N-terminal 
regions of Cdc20 and Cdh1 have been found to directly interact with substrates (Pfleger 
et al., 2001), and the WD40 propeller domain of Cdh1 (located in its C-terminal half) to 
directly interact with the destruction box motif (Kraft et al., 2005).   These studies both 
argue for coactivators conferring substrate specificity on the APC, albeit through 
different mechanisms, as does biochemical evidence of Cdh1-substrate complexes 
(Burton et al., 2005; Schwab et al., 2001).  An intermediate model has also been 
proposed, in which both core APC subunits and coactivators contribute to substrate 
binding (Passmore and Barford, 2005).   
 
Regulation of Cdh1 
Cdh1 possess 11 CDK consensus sites, and phosphorylated Cdh1 has significantly 
reduced ability to interact with the APC (Figure 1.5A) (Jaspersen et al., 1999; Zachariae 
et al., 1998a).  Consistent with this, overexpression of Cdh1-m11, in which the 11 CDK 
consensus phosphorylation sites are mutated to unphosphorylatable alanine residues, 
causes cell cycle arrest with low levels of Cdh1-APC targets (Zachariae et al., 1998a).  
Phosphorylation may also regulate Cdh1 localization: the Msn5 exporter may specifically 
recognized phosphorylated Cdh1 and transport it from the nucleus to the cytoplasm 
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(Jaquenoud et al., 2002).  Thus in addition to precluding direct APC interaction, Cdh1 
phosphorylation may also spatially segregate Cdh1 from relevant substrates and the APC 
itself, as APC subunits localized thus far have been nuclear (Huh et al., 2003; Sikorski et 
al., 1993).   
Other mechanisms may control Cdh1 activity.  Cdc5 (Polo kinase) has been 
reported to act in concert with CDK phosphorylation to mediate complete Cdh1 
inhibition (Crasta et al., 2008).  Specifically, Cdc5 has been demonstrated biochemically 
to be capable of phosphorylating Cdh1 on serines 125 and 259 (Figure 1.5B) (Crasta et 
al., 2008).  It has been proposed, through a series of overexpression studies, that 
phosphorylation of Cdh1 on these sites is required for complete Cdh1 inactivation, to 
allow for spindle pole body separation and mitotic spindle assembly.  This Cdc5-
mediated inhibition of Cdh1 is reported to be essential in the absence of the 
stoichiometric inhibitor ACM1 (Crasta et al., 2008) (see below).   
Cdh1 in yeast is stable and present throughout the cell cycle (Prinz et al., 1998; 
Zachariae et al., 1998a).  In contrast, vertebrate Cdh1 levels are cell cycle regulated 
(Kramer et al., 2000); Cdh1 is degraded in S phase by an SCF-complex (Benmaamar and 
Pagano, 2005), and mediates its own degradation in G0/G1 (Listovsky et al., 2004).   
Stoichiometric inhibitors also regulate APC-Cdh1: Acm1 in budding yeast 
(Figure 1.5C), Rca1 in Drosophila, and Emi1 in vertebrates.  Rca1 and Emi1 are F-box 
proteins that are homologous to each other (Reimann et al., 2001).  Acm1 has no obvious 
sequence homology, but is functionally similar; all are unstable cell-cycle regulated 
pseudosubstrate inhibitors of APC-Cdh1 that are transcribed in G1/S.  rca1 flies degrade 




Figure 1.5 Regulatory mechanisms inhibiting Cdh1 activity.  A CDK activity results in 
the phosphorylation of Cdh1 on some or all of 11 putative sites. This phosphorylation 
blocks Cdh1 association with the APC.  G1 and S phase cyclins, and possibly early 
mitotic cyclins, are reported to contribute to this phosphorylation.  B Cdc5 (polo kinase), 
appearing late in mitosis, can phosphorylate Cdh1 on at least two residues, and this is 
reported to block Cdh1 association with the APC.  C The stoichiometric inhibitor Acm1 
is transcribed in G1 and blocks Cdh1 targeting of substrates.    
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Consistently, Emi1 may inhibit APC-Cdh1 so as to stabilize mitotic cyclins in interphase, 
promoting mitosis and preventing rereplication (Di Fiore and Pines, 2007).  acm1 
deletion has no obvious phenotype, although it exhibits modest synthetic interactions 
with deficiency in the Swe1 CDK-regulatory kinase (Martinez et al., 2006).  Acm1 may 
be a Cdh1 target (Enquist-Newman et al., 2008), but has also been reported to be 
destroyed in an APC-independent manner (Hall et al., 2008; Ostapenko et al., 2008).   
 
Regulation by multisite phosphorylation 
The presence of 11 putative CDK sites in Cdh1 is a striking example of multisite 
phosphorylation, a common phenomenon in phosphorylation control (Holt et al., 2009) 
that features prominently among cell-cycle regulated proteins.  Cdh1 can be inhibited by 
phosphorylation of some or all of its 11 CDK sites; how the various sites contribute and 
whether this regulation is a critical regulatory mechanism has been unclear.  By 
overexpression of a series of alleles progressively lacking phosphorylation sites 
beginning with the N-terminus, a seemingly continuous decrease in resultant Clb2 levels 
was found (Zachariae et al., 1998a), suggesting that all tested clusters of sites contribute 
approximately additively.  Cdh1 phosphorylation decreases sharply upon mitotic exit as 
mitotic cyclin levels fall and the phosphatase Cdc14 is released, and then increases 
sharply during progression through G1, based on phosphorylation-dependent gel shifts 
(Zachariae et al., 1998a); these gel shifts have not been correlated to specific 
phosphorylations.  The function and existence of intermediate phosphorylation states of 
Cdh1, whether the different sites are functionally distinct from one another, and how the 
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presence of multiple sites contributes to the regulatory architecture of the APC remains 
unclear.   
A global analysis of CDK substrate phosphorylation sites in budding yeast found 
evidence for large numbers of poorly evolutionarily conserved clusters of 
phosphorylation sites in relatively unstructured regions, likely acting through bulk 
electrostatic effects with some regional specificity (Holt et al., 2009).  Indeed, while a 
high density of N-terminal Cdk sites is conserved throughout eukaryotic evolution, their 
precise location has diverged even in rather closely related yeast species, consistent with 
this bulk electrostatic model.   
Multisite phosphorylation of the Sic1 CDK inhibitor may control Sic1 proteolysis 
by a counting mechanism, whereby phosphorylation of any 5 of 9 candidate Cdk sites 
allows for binding of the SCF activator Cdc4, consequently promoting Sic1 degradation 
and the progression to S phase (Nash et al., 2001).  The apparent precision of this 
mechanism is hard to square with the bulk electrostatic proposal, and the molecular basis 
for this specificity remains unclear. 
 In the case of Sic1, it has been argued that multisite phosphorylation serves both 
to set a delay and establish a threshold for CDK activity (Nash et al., 2001).  Simple 
mathematical models support this; six fast phosphorylations create a sharp transition with 
a temporal delay, whereas single fast phosphorylation lacks the temporal delay and a 
single slow phosphorylation lacks the dynamic range (Deshaies and Ferrell, 2001).   
 It is not known if Cdh1 is regulated in a similar fashion, or whether functional 
distinctions exist between the various phosphorylation sites, which might differentially 
regulate APC interaction and Msn5 interaction. 
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Kinases responsible for Cdh1 inactivation, and regulatory implications 
Numerous kinases have been reported to be involved in the phosphorylation-
driven inactivation of Cdh1.  Initial studies implicated the G1 cyclins in the inactivation 
of what we now know is APC-Cdh1 (Amon et al., 1994); more recent work has argued 
for an additional role for the early expressed B-type cyclins—specifically the S phase 
Clb5 and the mitotic Clb3 and Clb4 cyclins—in Cdh1 inactivation (Huang et al., 2001; 
Yeong et al., 2001).  However, the relative contribution of G1, S-phase, and mitotic 
cyclins is unclear.  Later mitotic cyclins (Clb1,2) may maintain inhibitory Cdh1 
phosphorylation, although this has not been demonstrated directly.   
It is important to know the predominant kinase or kinases responsible for 
inhibitory Cdh1 phosphorylation.  As Cdh1 drives mitotic cyclin degradation, if it is itself 
inactivated by mitotic Clb-CDK activity, this may allow for a positive feedback loop 
architecture governing Cdh1 activity rooted in Cdh1 phosphorylation.  However, while 
Cdh1 targets the mitotic cyclins Clb2 and Clb3 (Zachariae et al., 1998a), and by 
homology most likely Clb1 and Clb4, in contrast the S phase cyclin Clb5 is a poor Cdh1 
substrate.  A physiologically significant role for Clb5 in Cdh1 inactivation would likely 
couple Cdh1 regulation to a Cdc20-Clb5 negative feedback oscillator (Cross, 2003).  
Cdc20 is required for cell-cycle appropriate Clb5 destruction (Shirayama et al., 1999), 
although the SCF has also been reported to degrade it (Bai et al., 1996). Alternatively, as 
SCF and not the APC is responsible for destruction of the S-phase cyclin Clb6 (Jackson 
et al., 2006) and the G1 cyclins, their involvement in Cdh1 inactivation would dictate still 
different circuitry. 
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Interestingly, deletion of CLB5 rescues viability of cdc20 pds1 strains (Shirayama 
et al., 1999); one interpretation of this is that the deletion of CLB5 results in a shift of 
Cdh1 to less phosphorylated and thus less inhibited state that allows for mitotic exit, 
likely through mitotic Clb destruction (Wäsch and Cross, 2002).  The presence of such 
circuitry does not preclude regulatory phosphorylation by G1 or mitotic cyclins, or still 
other kinases, which could contribute in an additive or synergistic fashion.       
 
 Mapping of Cdh1 phosphorylation sites 
 Mass spectroscopy has confirmed extensive phosphorylation of Cdh1 in vivo, 
including both CDK and non-CDK sites (Hall et al., 2004).  These included six CDK 
sites—T12, T157, T173, T176, S239, and S436—as well as possible phosphorylation of 
S16 and S169 (whose peptides had other potentially phosphorylatable residues, and for 
which there was not adequate tandem mass spectrometry data for exact site 
determination).  At least nine other non-CDK phosphorylation sites were also detected 
(Hall et al., 2004).  Most Cdh1 molecules contained between four and five phosphates 
(Hall et al., 2004).   Mass spectroscopy on Cdh1 with either CDK or non-CDK sites 
ablated suggested dependence of non-CDK-site phosphorylation on CDK sites, but not 
the reverse (Hall et al., 2004).  The reported in vitro Cdc5 phosphorylation sites S125 and 
S259 (Crasta et al., 2008) were not detected in vivo (Hall et al., 2004).  The pattern of 
Cdh1 phosphorylation does not appear to change from inactivation in S-phase until the 
end of mitosis (Hall et al., 2004); this may argue against significant CDK inhibition by 
kinases that are expressed beyond S-phase, such as Cdc5.   
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Cdh1 in vertebrate development 
Cdh1 functions as a G1 stabilizer, and in budding yeast, it is required for proper 
pheromone-induced G1 arrest (Schwab et al., 1997).  G1 stabilization may allow Cdh1 to 
function as a developmental regulator in metazoans.  In neurons, Cdh1 targets Id2 
(Inhibitor of Differentiation 2) for destruction, coupling cell cycle exit and 
differentiation/axonal growth (Lasorella et al., 2006).  Cdh1 has been implicated in the 
differentiation of non-neural tissues as well (Li et al., 2007), and thus could couple cell 
cycle exit and differentiation.    
 
Rationale for the present study 
This thesis examines how APC-Cdh1 is regulated, and the consequences of 
misregulating its activity.  All studies are done in the budding yeast Saccharomyces 
cerevisiae, a haploid eukaryote whose cell cycle is well characterized and substantially 
conserved with higher eukaryotes.  Genetic manipulation of S. cerevisiae is extensively 
developed, including homologous recombination that allows for precise alterations of 
endogenous genes.  
Most previous work on Cdh1 has relied heavily on overexpression, resulting in 
conflicts over mechanisms and significance of APC-Cdh1 regulation.  Here we employ 
exact gene replacements and careful cell biological characterization to clarify key 




Requirements and reasons for effective APC-Cdh1 inhibition 
 
Inhibitory CDK phosphorylation of Cdh1 is essential 
CDH1-m11, which lacks all CDK phosphorylation sites (Figure 2.1), is lethal 
when overexpressed (Zachariae et al., 1998a) but has been reported to allow viability 
when carried on a plasmid under control of its endogenous promoter, suggesting the 
former result to be an artifact of overexpression (Jaquenoud et al., 2002) .  To determine 
rigorously whether CDK-mediated Cdh1 phosphorylation was required for viability at 
endogenous expression levels, we sought to create an exact chromosomal gene 
replacement of CDH1 with CDH1-m11.  We used a recombination-based approach, in 
which two copies of cdh1-m11, each rendered non-functional by insertion of different 
selectable markers at different positions, were arranged in tandem at the endogenous 
locus.  Recombination between the two copies can be selected for, and recombinants 
simply scored for retention of the insertional markers.  CDH1-m11 exact gene 
replacements should lack both markers (Figure 2.2).  No recombinants yielding 
uninterrupted CDH1-m11 were obtained (Figure 2.2).  The critical region for this 
recombination did yield frequent recombinants using a control allele, comprised of two 
similarly interrupted cdh1-m11 alleles in the opposite order.  Recombinants using the 
control allele will all be non-functional due to retention of insertional marker(s).  These 



















Figure 2.1  CDH1 alleles constructed for this chapter.  CDH1-m11 (top) has the eleven 
putative CDK phosphorylation sites mutated to alanines (red dots), such that the resultant 
protein is unphosphorylatable by CDK.  CDH1-pkm (middle) has the two known Cdc5 
(Polo-like kinase) sites mutated to alanine.  CDH1-pbm (bottom) codes for an alanine 
substitution in the first residue of the polo binding box, such that it ablates the polo 







Figure 2.2 Cdh1 inhibition requires CDK phosphorylation.  A. Recombination-based 
strategy used to obtain CDH1-m11 as an exact gene replacement (top), and control 
recombination (bottom).  Horizontal bracket indicates region of recombination that 
recreates either CDH1-m11 or the doubly-interrupted control cdh1-m11.  B. Percentage 
of CDH1-m11 or control disrupted cdh1-m11 alleles recovered as determined by 




CDH1-m11 gene replacement could be deleterious due to unregulated APC 
activation; however, previous studies have suggested an APC-independent mechanism 
for lethality of overexpressed Cdh1-m11 (Thornton et al., 2006).  Cdc23 is an essential 
subunit of the APC; cdc23-1 is hypomorphic for APC-Cdh1 activity even at the 
permissive temperature (Schwab et al., 2001).  In contrast to failure of recovery of 
CDH1-m11 recombinants in a CDC23 background, CDH1-m11 cdc23-1 recombinants 
were readily obtained (Figure 2.2), and confirmed to be exact by mapping and 
sequencing of PCR products from the recombinants.  When we attempted to cross these 
recombinants to CDC23 strains, doubly heterozygous diploids were not obtainable, 
suggesting that CDC23 and CDH1-m11 made a dominantly lethal combination and that 
the lethality of CDH1-m11 is APC dependent. 
 This result enabled us to perform a high copy suppressor screen for CDH1-m11, 
by transforming a wild type strain with a genomic library, crossing the pool of 
transformants to a CDH1-m11 cdc23-1 strain at the permissive temperature, and selecting 
for viable diploids.  High-copy ACM1 was isolated multiple times in independent clones 
from the genomic library, but no other strong positives were obtained.  We found that we 
could readily construct GAL-ACM1 CDH1-m11 strains that were viable on galactose 
medium (GAL-ACM1 on, Acm1 overexpressed) but inviable on glucose medium (GAL-
ACM1 off, only endogenous levels of Acm1 present) (Figure 2.3).  We carried out a high-
copy plasmid suppression screen for viability of such a strain on glucose medium, once 
again obtaining only multiple ACM1 clones.  These results suggest (but do not prove) that 








Figure 2.3 Cdh1 inhibition does not require Cdc5 phosphorylation or Acm1.  A. Tenfold 
serial dilutions performed on strains containing galactose-inducible Acm1 and the 
indicated CDH1 exact gene replacements. B. DIC images of strains from (A) after 8 
hours in glucose.  Note the hyperpolarized growth present only in CDH1-m11 strains.  




Cdc5 phosphorylation of Cdh1 is not required for cell viability 
 Cdc5 has been reported to act in concert with CDK phosphorylation to mediate 
complete Cdh1 inhibition (Crasta et al., 2008).  Cdc5 can phosphorylate Cdh1 on serines 
125 and 259 (Crasta et al., 2008).  It has been proposed that phosphorylation of Cdh1 on 
these sites is required for complete Cdh1 inactivation, to allow for spindle pole body 
separation and mitotic spindle assembly.  Furthermore, Cdc5-mediated inhibition of Cdh1 
was reported to be essential in the absence of ACM1 (Crasta et al., 2008).  However, 
these experiments were all carried out under conditions of overexpression.  Therefore, we 
created an exact gene replacement ablating these two known sites of Cdc5 
phosphorylation (‘CDH1-pkm’) (Figure 2.1).  We initially introduced this gene 
replacement into a cdc23-1 background (see above), and confirmed the structure of the 
CDH1-pkm allele by sequencing of PCR products.  We then crossed this allele into a 
CDC23 GAL-ACM1 background.  The resulting CDH1-pkm GAL-ACM1 CDC23 strains 
were not dependent on ACM1 overexpression for viability, as evidenced by complete 
viability upon shutoff of GAL-ACM1 (Figure 2.3), and Mendelian recovery of fully viable 
CDH1-pkm CDC23 segregants lacking GAL-ACM1 (data not shown). 
 It has been argued that endogenous Acm1 restrains Cdh1 in the absence of Cdc5 
phosphorylation (Crasta et al., 2008). However, CDH1-pkm acm1 strains were viable 
with no obvious growth or morphological defects.  Efficient degradation of the major 
mitotic cyclin Clb2 is Cdh1-dependent (Schwab et al., 1997; Visintin et al., 1997), and 
CDH1-pkm acm1 strains accumulate and destroy Clb2 with normal kinetics  (Figure 2.4).  
It was reported that the lethality of Cdh1 lacking Cdc5 phosphorylation sites was the 










Figure 2.4 Clb2 oscillation is not altered in CDH1-pkm cells.  A Time course of cells of 
the indicated genotype released from an α-factor block, and immunoblotted against Clb2.  
B Quantification of Clb2 levels from strains in A, normalized to Pgk1.   
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cells with separated and unseparated SPBs in asynchronous cultures of CDH1-pkm acm1 
strains (Figure 2.5). 
These results rule out any significant role in Cdh1 inhibition for Cdc5 
phosphorylation of S125 and S259, the only known Cdc5 sites in Cdh1.  However, there 
could be other unidentified Cdc5 sites.  While phosphorylation of S125 and S259 was not 
detected in a mass spectrometry survey, phosphorylation of numerous other non-CDK 
sites was observed (Hall et al., 2004). Cdc5-dependent phosphorylation of diverse targets 
requires polo box binding motifs (PBBs) in the substrate.  PBBs have the consensus 
sequence S-pS/pT-P, with the required phosphorylation frequently created by proline-
directed CDK activity (Elia et al., 2003).  There are four such sites in Cdh1, which were 
collectively demonstrated to promote binding of Cdc5 to CDK-phosphorylated 
Cdh1(Crasta et al., 2008).  Therefore, we constructed a CDH1 allele in which the initial 
serines in the four PBBs were mutated to alanines (Figure 2.1).  This manipulation is 
predicted to block Cdc5 binding but not CDK phosphorylation (since the initial S is not 
part of the CDK consensus S/T-P).  This allele, CDH1-pbm, thus may uncouple CDK 
from Cdc5 phosphorylation.  Previous experiments eliminated the PBB by mutating the 
CDK sites themselves, which makes results ambiguous as to whether Cdc5 or CDK is the 
relevant kinase being prevented from phosphorylating Cdh1 (Crasta et al., 2008).   
Using the same strategy as described above for CDH1-pkm, we constructed an 
exact gene replacement of CDH1 with CDH1-pbm, and found that this allele had no 
discernible cell-cycle phenotype and no dependence on ACM1 for viability (Figure 2.3). 
Overall, our results from endogenous expression levels of Cdh1 do not support a 










Figure 2.5 Bipolar spindle assembly is not altered in CDH1-pkm cells. A CDH1-pkm 
strains form morphologically normal long and short spindles, images from fixed cells 
from an asynchronous population B Percentage of asynchronous CDH1 and CDH1-pkm 
cells with separated SPBs.  
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expression levels, in sharp contrast to the essentiality of CDK-dependent phosphorylation 
of Cdh1.  We cannot formally exclude the possibility that there are other sites of Cdc5 
phosphorylation and/or other non-consensus PBBs; however previous biochemical work 
argues against this (Crasta et al., 2008).   
 
CDH1-m11 at the endogenous locus results in first-cell-cycle arrest with replicated 
DNA, hyperpolarized bud growth, low levels of Cdh1 target proteins, and a 
heterogeneous spindle pole body phenotype 
To determine the lethal phenotype of cells expressing Cdh1-m11 (CDK-
unphosphorylatable) at endogenous levels, we arrested GALL-HA-ACM1 CDH1-m11 
cells (GALL is a weakened version of the GAL1 promoter (Mumberg et al., 1994)) in G1 
using α-factor in galactose medium.  We transferred the cells to glucose medium to turn 
off the GALL promoter and deplete HA-Acm1, and then released the α-factor block. By 
immunoblot, HA-Acm1 was greatly reduced in α-factor as expected (Enquist-Newman et 
al., 2008; Hall et al., 2008; Ostapenko et al., 2008), and undetectable after glucose 
incubation.  Both CDH1-m11 and CDH1 control cells released synchronously and with 
comparable kinetics from the α-factor block, as indicated by bud emergence and 
expression of Clb5 (Figure 2.6).  Clb5 is an early-expressed B-type cyclin that promotes 
DNA replication, and that is not sensitive to Cdh1 (Figure 2.6B); consistent with timely 
Clb5 accumulation, kinetics of DNA replication in CDH1-m11 and CDH1 cells were 
indistinguishable (Fig 2.6C).  Clb5 levels then declined, remaining at approximately a 










Figure 2.6 CDH1-m11 results in a first-cycle arrest.  A CDH1-m11 or CDH1 cells (both 
GALL-HA-ACM1) were arrested in G1 with α-factor, depleted of HA-Acm1, and 
synchronously released.  Fluorescence microscopy of Myo-mCherry (red) marking the 
bud neck, and Tub1-CFP (cyan) were taken at the indicated timepoints after release from 
α-factor.  CDH1-m11 cells multiply bud as indicated by multiple Myo1 rings.  Tubulin 
signal varies in appearance from a point to a short bar, but elongated spindles are not 
observed.  Scale bar is 5 microns.  B Immunoblots of cells as in (A) detecting the 
indicated proteins.  Pgk1 is a loading control.  ‘afG’ cells are in α-factor prior to glucose 
introduction. C Bulk DNA flow cytometry of cells as in (A). 
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In contrast, accumulation of the later-expressed mitotic cyclin Clb2 was 
significantly reduced in CDH1-m11 cells, with about a 15-fold reduction in peak Clb2 
levels compared to CDH1 controls.  This is consistent with effective Cdh1 deregulation 
by the CDK site mutations, since Clb2 is a known Cdh1 target.  Clb2 expression drives a 
switch from polarized to isotropic bud growth, and this is blocked in CDH1-m11 cells 
(Figure 2.6A).  Accumulation of Cdc5, another known Cdh1 target, was similarly 
reduced in CDH1-m11 cells.  Interestingly, the timing of initial accumulation of both 
Clb2 and Cdc5 was similar in CDH1 and CDH1-m11 cells.  
CDH1-m11 cells do not undergo anaphase or cytokinesis.  They continue 
polarized bud growth, and rebud as evidenced by accumulation of fluorescent Myo1-
mCherry (a bud site marker) at a novel location along the initial hyperpolarized bud 
(Figure 2.6A) and/or by a new bud.  Spindle morphogenesis appeared defective: 
Tub1(beta-tubulin)-CFP revealed a range of morphologies from single dots to short bars 
was detected (Figure 2.6A).    
To more accurately examine spindle morphogenesis, we used SPC42-CFP and 
TUB1-GFP to label the spindle pole body and microtubules.  In these double-labeled 
cells, an intact bipolar spindle will appear as two distinct blue Spc42-CFP signals 
connected by a bridge of green Tub1-GFP (Spc42-CFP and Tub1-GFP fluorescent 
signals were sufficiently spectrally separated to make this determination).  Such spindles 
were almost uniformly observed in CDH1 controls; at 60 minutes after release over 80% 
of cells had clearly separated SPBs.  In contrast, 70% of CDH1-m11 cells had a single 
focus of Spc42-CFP signal (Figure 2.7).  We expect, from previous work, that this single 
Spc42 signal represents duplicated but unseparated SPBs (Crasta et al., 2008; Fitch et al., 
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1992).  Consistent results were obtained with SPC42-CFP alone, as well as with SPC29-
YFP and untagged SPC42, suggesting that the tags did not significantly affect the results.   
30% of CDH1-m11 cells contained short bipolar spindles that did not progress 
through anaphase.  We considered several mechanisms that could account for anaphase 
failure.  If the spindles are aberrant in structure or kinetochore attachment this could 
trigger the spindle assembly checkpoint to prevent anaphase.  However, deletion of the 
critical checkpoint component MAD2 had no effect on spindle assembly or function in 
CDH1-m11 cells (Figure 2.8). 
A failure of cohesin cleavage not dependent upon checkpoint activation could 
also explain failure of anaphase.  Cdh1 has been reported to target Cdc20 for destruction 
in vivo.  Cdc20 promotes anaphase by degradation of the separase inhibitor Pds1, 
allowing cleavage of the cohesin complex subunit Scc1; sister chromatids can then 
separate upon loss of cohesion.  Failure to accumulate sufficient Cdc20, if it results in an 
inability to clear Pds1, could account for persistent short bipolar spindles.  We find that 
CDH1-m11 cells fail to accumulate Cdc20 (Figure 2.9A).   
If failure to accumulate Cdc20 accounts for anaphase failure, then Pds1 should 
remain at high levels in CDH1-m11 cells.  Indeed, we find that Pds1 remains present at 
near-peak levels at the CDH1-m11 induced block (Figure 2.9B).  Thus Pds1 
accumulation and consequent failure of cohesin cleavage could account for anaphase 
failure.  Consistent with this idea, scc1-73, a temperature sensitive allele of a cohesin 
complex subunit, promotes increased spacing between SPBs at the restrictive temperature 
in CDH1-m11 cells, indicating that inability to cleave cohesin contributes to the short 





Figure 2.7 CDH1-m11 cells have a variable spindle pole body phenotype. A 
Fluorescence microscopy for Spc42-CFP (cyan) Tub1-GFP (green) and Myo1-mCherry 
(red); 30% of CDH1-m11 cells form bipolar spindles, as indicated by two separate Spc42 
dots connected by intervening tubulin-GFP.  Strains were treated as in Figure 2, images 
taken 180 minutes after release.  Scale bar: 5 microns. B Percentage of cells from (A) 










Figure 2.8  Maintenance of short bipolar spindles in CDH1-m11 cells is not dependent 
on MAD2 A Micrographs of mad2 CDH1-m11 or mad2 CDH1 strains 120 minutes after 
release from α-factor.  Scale bars are 5 microns. B  Percentage of cells from (A) with 















Figure 2.9 CDH1-m11 cells accumulate Pds1 but not Cdc20 A Immunoblots against 
strains synchronously released from α-factor with endogenously tagged Cdc20 and either 
CDH1 or CD1-m11, and right, quantification of normalized Myc-Cdc20 levels from 
immunoblots.  B Left: immunoblots against strains synchronously released from α-factor 
with endogenously tagged Pds1 and either CDH1 or CDH1-m11; right, quantification of 









Figure 2.10 CDH1-m11 cells lengthen their spindles upon cohesin inactivation.  A 
Average distance between SPBs in CDH1-m11 SCC1 and CDH1-m11 scc1-73 cells at the 
restrictive temperature, two hours after α-factor release.  B. Histogram of the length 
distribution of spindles in the cells from (A). C Fluorescence microscopy of strains from 
(A) observing the SPB protein Spc29-YFP (yellow) and nuclear Histone2B-mCherry 
(red). 
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Cdc20 was reported to promote Pds1 proteolysis much more effectively than 
mitotic cyclin proteolysis, and Cdh1 was reported to have the opposite specificity 
(Visintin et al., 1997).  Our results are consistent with this idea, since Pds1 persists in the 
face of unregulated Cdh1-m11.  Surprisingly, Pds1 is efficiently targeted by purified 
APC-Cdh1 in vitro (Rodrigo-Brenni and Morgan, 2007; Thornton et al., 2006), 
suggesting some additional level of control of proteolysis in vivo.   
We noted grossly abnormal nuclear morphology, as monitored with histone H2B-
mCherry, in CDH1-m11 cells, whether or not they contained a bipolar spindle (Figure 
2.12).  Time-lapse microscopy shows H2B-mCherry signal ‘meandering’ along the 
hyperpolarized bud and the mother cell body.  Microscopic observations of fixed cells 
with labeled SPBs and tubulin suggested that this aberrant nuclear migration may be 
dependent on astral microtubules, since extended mCherry signal frequently coincided 
with long microtubules that were not terminated with an SPB (Figure 2.11).  We do not 
know the reason for this phenotype, which has not been described previously to our 
knowledge.  
 
Spindle Pole Body separation in CDH1-m11 cells is dependent on endogenous ACM1 
 The heterogeneous spindle pole body phenotype of CDH1-m11 cells suggested 
the possibility that the level of APC-Cdh1 activity in these cells is close to a threshold for 
spindle morphogenesis.  We reasoned that endogenous Acm1 might titrate a sufficient 
level of Cdh1-m11 to keep the system near this threshold.  Consistent with this idea, 
CDH1-m11 acm1 cells completely failed to separate spindle pole bodies: <1% of cells, 






Figure 2.11 CDH1-m11 results in aberrant nuclear division in the absence of SPB 
separation.  A Micrographs of fixed CDH1-m11 or CDH1 cells 3 hours after release from 
α-factor, Htb2-mCherry (red) and Myo1-GFP (green)  Scale bars are 5 microns.  B 
Frames from time lapse microscopy of the same strain at the indicated times after release 
from α-factor imaged for Histone-mCherry.  Note the ability to divide Histone-mCherry 
asymmetrically, as well as the subsequent fusion of the two connected nuclear blobs. C 
CDH1-m11 strains with Spc29-YFP marking the spindle pole body as well as Tub1-CFP 
and Htb2-mCherry were released from α-factor, with the depicted images taken 3 hours 
after release.  Aberrant nuclear morphology with unseparated spindle pole bodies are 
apparent.  Adjusted CFP-channel contrast (bottom) reveals microtubule structures 




Figure 2.12 The CDH1-m11 strain spindle pole body phenotype is modulated by 
endogenous ACM1. A Fluorescence microscopy of indicated genotypes performed as in 
Figure 2.7.  In CDH1-m11 acm1 cells, tubulin can be seen emanating from SPBs, but 
separated SPBs are not observed. 2XACM1 CDH1-m11 cells separate spindle pole bodies 
and form bipolar spindles.  B Percentage of synchronized acm1∆, wild type (1X ACM1), 
and 2X ACM1 cells displaying separated spindle pole bodies at indicated timepoints. C 
Clb2 levels for indicated genotypes at 60 minutes after release from α-factor, 
standardized to Pgk1 loading control. D Tenfold dilution assay for ACM1 allelic series of 
strains, as in (A); note that less than 1% of 2XACM1 CDH1-m11 cells form colonies. 
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If Cdh1-m11 is near a threshold for inhibition by Acm1, then increasing ACM1 gene 
dosage should strongly increase APC-Cdh1 inhibition.  To test this, we integrated a 
genomic segment containing ACM1 at the URA3 locus in a GALL-ACM1 CDH1-m11 
background.  We assessed ACM1 copy number by quantitative PCR, and found clones 
with two, three or five copies of ACM1 (including the endogenous locus).  Five copies of 
ACM1 fully rescued viability of CDH1-m11 cells, consistent with the high-copy plasmid 
suppression results described above.  However, 2 or 3 copies were essentially insufficient 
for rescue (approximately three to four logs drop in viability upon shutoff of GAL-ACM1 
expression) (Figure 2.12D).  
Despite lack of rescue of overall viability, 2X ACM1 CDH1-m11 GALL-ACM1 
cells were almost all able to form a short bipolar spindle upon GALL-ACM1 shutoff 
(Figure 2.12A, B).  Strikingly, these cells nevertheless almost quantitatively failed to 
progress to anaphase.    
These results suggest that multiple events in spindle morphogenesis and function 
are inhibited by Cdh1-m11, since failure of short spindle formation could be 
quantitatively uncoupled from subsequent anaphase failure by increase ACM1 gene 
dosage.  It is likely that graded increases in Acm1 levels are accompanied by graded 
inhibition of Cdh1-m11, as Clb2 levels in CDH1-m11 strains correlates with ACM1 copy 
number (Figure 2.12C).  This suggests that different events regulated by Cdh1 have 




Restoring levels of the Cdh1 target kinesin Cin8 does not restore spindle pole body 
separation in CDH1-m11 cells 
Previous work suggested that failure to produce a bipolar spindle without restraint 
of Cdh1 activity was due specifically to degradation of plus-end kinesins Cin8 and Kip1, 
since a short bipolar spindle could be obtained by overexpression of undegradable Cin8 
in the absence of Cdc28 activity, (which is required for inhibition of  APC-Cdh1) (Crasta 
et al., 2006).  We sought to test this idea more directly, with endogenous levels of 
expression of both Cdh1-m11 and undegradable Cin8.  We used the CIN8-alaKEN allele 
(Hildebrandt and Hoyt, 2001), in which the KEN box required for Cdh1-mediated Cin8 
degradation was mutated to AAA.  Myc-tagged alleles of either CIN8 or CIN8-alaKEN 
were placed at the endogenous locus (with an untagged CIN8 allele downstream) in 
CDH1-m11 GAL-ACM1 strains.  By Western blot, Myc-Cin8 was readily detected in 
wild-type cells and was found at lower levels in CDH1-m11 cells after GAL-ACM1 
shutoff compared to CDH1 controls; Myc-Cin8-alaKEN was detected in comparable 
levels in both backgrounds (Figure 2.13C).  These results are expected since the KEN 
mutation prevents Cdh1-dependent proteolysis of Cin8  (Hildebrandt and Hoyt, 2001).  
Consistently, we found similar results using the CIN8-KED mutation to inactivate the 
Cin8 KEN box (Hildebrandt and Hoyt, 2001).  Thus, reduction of Cin8 in CDH1-m11 
cells is specifically due to Cdh1-Cin8 interaction via the Cin8 KEN box.  
Despite restoration of Cin8 protein levels by the alaKEN mutation, MYC-CIN8-
alaKEN had essentially no effect on the terminal spindle phenotype of Cdh1-m11 cells 
compared to MYC-CIN8 or CIN8 controls (Figure 2.13A, B).  The Myc tag on Cin8 was 
shown previously to be fully compatible with Cin8 function (Hildebrandt and Hoyt, 
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2001).  Therefore, restoration of Cin8 at physiological levels to Cdh1-m11 cells is not 
sufficient to allow bipolar spindle formation, strongly suggesting the existence of other 
Cdh1 targets that are required for bipolar spindle formation.  Previous results suggesting 
that restoring Cin8 might be sufficient for bipolar spindle formation (Crasta et al., 2006) 
could be explained by the idea that overexpressed Cin8 could exert a strong pulling or 
polymerizing force between the two SPBs, or could be due to a lack of equivalence 
between the hypomorphic CDC28 allele and complete failure of Cdh1 phosphorylation.   
 
Consequences of restoring mitotic cyclins to a Cdh1-m11 block 
The Cdh1-m11 arrest is associated with destruction of cell cycle regulators 
(mitotic cyclins, Cdc5) as well as spindle components (see above).  Mitotic cyclins 
modulate numerous cell cycle processes.  Some cell cycle defects in CDH1-m11 cells 
could be due specifically and solely to mitotic cyclin proteolysis.  To test this, we placed 
Clb2-kd, an undegradable version of Clb2 lacking both KEN and destruction boxes and 
therefore immune to APC-mediated proteolysis (Wäsch and Cross, 2002) under the 
control of the MET3 promoter, and turned on expression by methionine deprivation in 
synchronized CDH1-m11 cells, after they were released from α-factor and allowed to 
bud.  Strikingly, the presence of CLB2-kd in CDH1-m11 cells largely eliminated the 
CDH1-m11 hyperpolarized bud growth phenotype (Figure 2.14, 15).  Cdc5 protein does 
not reappear after Clb2-kd expression, suggesting that APC-Cdh1-m11 remains active in 
the presence of undegradable Clb2.   
In addition, Clb2-kd had striking though variable effects on SPB and tubulin 




Figure 2.13 Cdh1-resistant CIN8 does not promote bipolar spindle assembly in CDH1-
m11 cells A  Fluorescence microscopy of cells with MYC-CIN8 or Cdh1-resistant MYC-
CIN8-ak (coding for Myc-Cin8-alaKEN, with KEN box residues mutated to alanine),  60 
minutes after release from α-factor block.  Scale bars are 5 microns. B Quantification of 
SPB separation of cells from A at indicated timepoints from α-factor release.  C 
Immunoblots of released cells.  Clb2 and exogenous HA-Acm1 are degraded normally.  






Figure 2.14 Restoration of mitotic cyclin Clb2 promotes bipolar spindle pole body 
separation in CDH1-m11 cells. A MET3pr-Clb2-kd cells, with either CDH1 or CDH1-
m11, were synchronized in α-factor, released, and Clb2-kd induced 60 minutes after 
release; images were obtained 180 minutes after α-factor release.  Scale bars: 5 microns.  
B Clb2 immunoblot for cells in A.  Clb2 antibody detects both endogenous Clb2 and 
Clb2-kd.  Pgk1 serves as a loading control.  C Quantification of cells with separated 
















Figure 2.15 Restoration of mitotic cyclin Clb2 restores isotropic growth in CDH1-m11 
cells. Single-cell time-lapse microscopy of strains of the indicated genotypes (all exact 
gene replacements), with minutes after release from α-factor indicated. 
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least two foci of SPC42-CFP signal, instead of the single signal predominantly observed 
in controls without Clb2-kd (Figure 2.14).  This effect was detectable when Clb2-kd 
levels were similar to those attained with Clb2-kd expressed from the endogenous locus, 
(this level was attained transiently, 30 minutes after induction; fully induced Clb2-kd 
levels from the MET3 promoter plateau at approximately threefold the level of Clb2-kd 
under its endogenous promoter).   
Spc42-CFP foci in CDH1-m11 MET3-CLB2-kd cells were sometimes associated 
with intervening Tub1-GFP signal, as in a normal metaphase spindle; in other cells, little 
or no polymerized tubulin could be detected.  Various other abnormal structures were 
observed, including multiple (three or more) Spc42-CFP foci.  The total signal intensity 
of Spc42-CFP foci in these cells at 180 minutes after release was approximately half that 
of either CDH1-m11 cells not expressing Clb2-kd or the same cells prior to Clb2-kd 
induction.  This suggests that duplicated SPBs separate in response to Clb2-kd 
expression, resulting in two foci, that each with a level of Spc42 comparable to a normal 
SPB (Figure 2.16).  Therefore, failure of SPB separation in CDH1-m11 cells might be 
specifically due to Cdh1-mediated degradation of Clb2 and other mitotic cyclins.  
Nevertheless, reintroduction of Clb2 into CDH1-m11 cells by this method results in 
severe disruption of normal spindle morphogenesis in most cells, perhaps due to 
alterations in microtubule dynamics (Higuchi and Uhlmann, 2005).  Normal spindle 
morphogenesis requires not only mitotic cyclin stabilization but also stabilization of other 
proteins, likely including spindle morphogenesis proteins such as Cin8, Ase1 and Fin1; 
we have not tested the effects simultaneous stabilization of multiple APC-Cdh1 













Figure 2.16 CLB2-kd induction in CDH1-m11 cells approximately halves the intensity of 
fluorescent SPB foci.  SPB intensity, assessed by an automated analysis, of the CFP-
channel images from the experiment described and depicted in Figure 2.14, for indicated 
time points. At least 200 cells were analyzed and averaged for each data point.  
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As noted above, Clb2-kd under the MET3 promoter was not much overexpressed 
in this experiment compared to the level of Clb2-kd expressed from the endogenous 
locus.  Consistent with this, comparable effects on cell polarity and spindle 
morphogenesis were obtained in CDH1-m11 cells bearing an exact endogenous gene 
replacement of CLB2 with CLB2-kd using single cell time-lapse analysis (Figure 2.15); 
however, these cells were partially defective in the α-factor block-release protocol, 
precluding clear quantification of bulk cultures. 
Thus, restoration of a physiological level of mitotic cyclins to strains with 
constitutively active APC-Cdh1 results in restoration of near-normal bud morphology, 
and also results in SPB separation.  Mitotic cyclin degradation is not responsible for all 
spindle phenotypes of CDH1-m11 cells, though, because spindle structure and 
microtubule dynamics likely are profoundly perturbed due to persistent APC-Cdh1 
activity even in the presence of stable mitotic cyclins. 
 
Discussion 
CDK phosphorylation is essential to restrain lethal activities of Cdh1 
Cdh1 is highly active in destruction of many important proteins, so multiple 
mechanisms of Cdh1 regulation might be expected.  CDK-mediated phosphorylation of 
Cdh1 inhibits Cdh1-APC interaction, and also promotes export of Cdh1 from the nucleus.  
The Acm1 protein is a stoichiometric Cdh1 inhibitor, most likely blocking access of even 
unphosphorylated Cdh1 to the APC.  Finally, Cdc5 (polo kinase) has been proposed to 
phosphorylate and inhibit Cdh1. 
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Here, we address the relative functional significance of CDK phosphorylation, 
Acm1 binding, and Cdc5 phosphorylation in control of Cdh1, at endogenous expression 
levels, using exact gene replacement.  We find that CDK phosphorylation is essential.  
Acm1 is not essential for effective Cdh1 regulation, but Acm1 binding contributes a 
buffering capacity.  We cannot detect a contribution of Cdc5 phosphorylation to Cdh1 
regulation by the assays we have used.   
The essentiality of CDK phosphorylation for Cdh1 regulation could be due to a 
phosphorylation requirement for blockage of Cdh1-APC interaction, for Msn5 interaction 
and nuclear export, or both.  Our experiments do not distinguish between these 
possibilities, although nuclear export is unlikely to be required for Cdh1 inhibition, as 
Msn5 is not essential. 
Our results show the benefits of exact gene replacement for accurate analysis.  
Overexpression of wild-type Cdh1 is lethal at sufficient levels, so lethality of any 
overexpressed mutant form of Cdh1 is necessarily ambiguous with respect to normal cell 
physiology.  A previous mention of viability of CDH1-m11 when present on a low-copy 
plasmid with the endogenous promoter (Jaquenoud et al., 2002) is on its face inconsistent 
with our results; however, we have found that including a 5’ untranslated fragment 
extending even into the next gene (ERP6) as a promoter for CDH1 on a low-copy 
plasmid is insufficient for effective complementation of cdh1 defects.  Plasmid-borne 
genes could potentially be underexpressed due to a truncated promoter or unknown 
effects of vector context; they clearly also can be overexpressed due to copy number or 
other effects.  Even stable integration of translocated copies of genes has the potential to 
mislead since such approaches invariably introduce unnatural neighboring sequences 
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(vector or chromosomal) that could affect expression.  In gene replacement (‘knock-in’) 
studies in animals, it has been recognized that removal of vector and marker sequences is 
required for unambiguous results (Wang et al., 1999)  
CDH1-m11 as an exact gene replacement yields a tight first-cycle arrest with 
uniform bud morphology and replicated DNA; this result identifies CDK phosphorylation 
as a critical physiological Cdh1 regulator.  In contrast to results with CDH1-m11 
overexpressors, the spindle phenotype of CDH1-m11 cells is heterogeneous; this result 
may have interesting consequences for the role of Acm1 (see below). 
Heterozygous CDH1-m11/CDH1 GAL-ACM1 diploids, while inviable upon 
shutoff of GAL-ACM1, nevertheless undergo efficient meiosis and sporulation without 
ACM1 overexpression.  This may be due to alternate Cdh1 inhibitory mechanisms that 
functions during the meiotic cell cycle; for example, the meiotic kinase Ime2 is capable 
of inhibiting Cdh1 on an alternate set of phosphorylatable residues (Holt et al., 2007). 
 
Cdh1 interferes with spindle morphogenesis at multiple steps 
While the most prominent spindle defect in CDH1-m11 cells is failure to make a 
short bipolar spindle, a significant minority of these cells do make a short spindle, as do 
almost all CDH1-m11 2X ACM1 cells.  CDH1-m11 cells with a short spindle (with or 
without doubled ACM1 gene dosage) nevertheless fail to undergo anaphase.  Our results 
suggest that this is likely due to failure of Pds1 proteolysis and resulting failure of 
cohesin cleavage. 
The failure of Pds1 proteolysis may be the consequence of severely depleted 
Cdc20 levels in CDH1-m11 cells.  APC-Cdh1 is required for efficient Cdc20 degradation 
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(Huang et al., 2001; Shirayama et al., 1998), although Cdc20 may also be degraded in an 
APC-independent manner (Goh et al., 2000).  We tested whether mutation of the two 
identified Cdc20 destruction boxes (Shirayama et al., 1998) would restore spindle 
morphogenesis to CDH1-m11 cells, with negative results; however, removing these two 
Cdc20 destruction boxes has a relatively minor effect on cell-cycle-regulated Cdc20 
accumulation (Prinz et al., 1998). Cdc20 may contain additional unidentified sequences 
targeting it for Cdh1-dependent degradation.  In a following chapter, we examine Cdh1- 
and destruction box-dependence of Cdc20 degradation. 
Cdh1-m11 might also alter CDC20 transcription.  Other factors contributing to 
anaphase failure in spindle-bearing CDH1-m11 cells could include proteolysis of other 
motor proteins or spindle components due to Cdh1-m11 activity; activation of the spindle 
checkpoint does not appear responsible. 
We have tested the hypothesis that one missing component for spindle 
morphogenesis is the mitotic cyclin Clb2, since mitotic cyclins are required for spindle 
morphogenesis (Fitch et al., 1992).  Indeed, introducing undegradable Clb2 into CDH1-
m11 cells results in apparent spindle pole body separation, with a proportion of cells 
displaying anaphase spindle-length separations.  This is not a complete explanation, 
though, since introducing undegradable Clb2 into CDH1-m11 cells resulted in disrupted 
or absent spindle morphology despite SPB separation in most cells.   
It has been proposed, based on overexpression studies, that Cdh1-dependent 
degradation of plus-end-directed motors, especially Cin8, could explain the requirement 
to inhibit Cdh1 for bipolar spindle morphogenesis.  Our results, at endogenous expression 
levels, fail to confirm this hypothesis.  Cin8 is indeed efficiently degraded in CDH1-m11 
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cells, and introducing the undegradable Cin8-KED or Cin8-alaKEN blocks this 
degradation as expected (Hildebrandt and Hoyt, 2001).  Nevertheless, undegradable Cin8 
was completely ineffective at restoring bipolar spindle formation to CDH1-m11 cells.  
Cin8 degradation may nevertheless contribute to failure of spindle formation in these 
cells, since plus-end-directed motors are required for this process.  One possible 
explanation is that the Cdh1 target Ase1 controls the physiological localization of Cin8; 
Ase1 proteolysis may prevent proper targeting of the stabilized Cin8 to the mitotic 
spindle (Khmelinskii et al., 2009). 
 
Acm1 as a physiological buffer 
Curiously, endogenous levels of ACM1 allow bipolar spindle formation in a 
minority of CDH1-m11 cells, since deletion of ACM1 eliminates these spindles; in 
contrast, doubling ACM1 copy number results in bipolar spindle formation in nearly all 
CDH1-m11 cells.  Thus Acm1 appears to be rather accurately titrated to a level just 
insufficient to inactivate completely unphosphorylated Cdh1, when both proteins are 
expressed at endogenous levels.  It is interesting to consider possible dynamic 
consequences of this effect.  Acm1 levels are tightly cell-cycle-regulated by changes in 
transcription and protein stability.   Acm1 levels higher than those in wild-type cells 
might sporadically allow premature bipolar spindle formation, before full inactivation of 
Cdh1 by complete CDK phosphorylation (since available evidence suggests that partial 
phosphorylation results in partial Cdh1 activity (Zachariae et al., 1998a)).  Lower levels 
than wild-type, in contrast, could put a demand on the system for much more efficient 
and quantitative Cdh1 phosphorylation than would otherwise be required.  
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These considerations cannot imply an essential role for regulation of Acm1 levels, 
since both strong overexpression and deletion are tolerated with little or no overt 
phenotype.  Subtle effects of ACM1 deletion or overexpression on fidelity of 
chromosome transmission have not been examined to our knowledge; perhaps even 
occasional chromosome mis-segregation has provided a sufficient selection to titrate 
Acm1 levels appropriately. 
 
Substrate Specificity of Cdh1 
The APC coactivators Cdc20 and Cdh1 target an overlapping set of proteins for 
proteasomal destruction; this substrate specificity likely contributes to the orderly 
progression through anaphase and exit from mitosis.  The mechanism by which this 
specificity is achieved remains contested.  As Cdh1 activity is effectively inhibited until 
late anaphase, it has been unclear whether failure of overexpressed Cdh1 to degrade 
targets such as Pds1 was the consequence of true substrate specificity or merely efficient 
pre-anaphase inhibition of Cdh1 activity.  The ability of purified APC-Cdh1 to efficiently 
ubiquitinate Pds1 (Thornton et al., 2006) argued for the latter case.  The arrest of CDH1-
m11 strains, in which Cdc20 does not accumulate, allows for a clean analysis of the 
proteolytic consequences of unrestrained Cdh1 activity in the context of an otherwise 
normal cell cycle.  Here we find that APC-Cdh1 is highly effective at clearing Clb2, 
Cdc5 and Cdc20, but far less capable of clearing Pds1 and Clb5.  This suggests that, in 
vivo, some physiological mechanism exists preventing Cdh1 from efficiently clearing 
Pds1.  Possibilities include direct biochemical regulation not recapitulated in the purified 
system, or activation of transcriptional circuitry sufficient to replenish the depleted 
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proteins.  This is possible, since CDH1-m11 cells likely have unrestrained SBF activity, 
resulting in accumulation of SBF transcriptional targets such as the G1 cyclin Cln2 
(Cross et al., 2002); PDS1 is in the SBF regulon (Spellman et al., 1998), which is 
inactivated by the Cdh1 target Clb2 (Amon et al., 1993).  Further, Clb2 promotes its own 
transcription as well as that of CDC20 (Amon et al., 1993; Zhu et al., 2000).  Such 
transcriptional circuitry could help ensure the proper order and function of APC 
coactivators; delayed inactivation of Cdh1 during a normal cell cycle could result in 
greater transcription of the G1 and S-phase cyclins that serve to inactive Cdh1, while 
inhibiting anaphase through Pds1 synthesis. 
 
Clb2-Cdh1 mutual antagonism 
In the case of spindle morphogenesis, Cdh1 acts at various thresholds, and most 
likely acts on multiple targets, to prevent final successful anaphase.  Mitotic cyclins are 
capable of restoring a separated spindle pole body phenotype in the context of CDH1-
m11; however these do not predominantly appear to be physiologically normal spindles, 
as evidenced by abnormal tubulin fluorescence and the frequent occurrence of more than 
two SPB foci.  This suggests that balance between Cdh1 and Clb2 permits specific steps 
such as spindle pole body separation to occur, with multiple other interactions and 
couplings present to orchestrate specific aspects of spindle physiology, including tubulin 
dynamics and spindle maintenance.  Complex dynamics have been described at the 
spindle midzone regulated by both APC-Cdh1 targets and net CDK phosphorylation 
(Fridman et al., 2009; Higuchi and Uhlmann, 2005; Khmelinskii et al., 2009)  In contrast, 
the hyperpolarized bud growth phenotype characteristic of CDH1-m11 cells is likely a 
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simple and direct consequence of removal of the mitotic cyclin Clb2, since its restoration 
to CDH1-m11 cells eliminates hyperpolarized bud growth in favor of isotropic growth.  
This presumably occurs either because Clb2 directly promotes isotropic growth, or 
because Clb2 inhibits expression of genes such as the G1 cyclin CLN2 that are directly 
driving polarized bud growth (Amon et al., 1994; Lew and Reed, 1993)   
 
The add-back approach 
Our strategy in this study, to first deregulate Cdh1 at the endogenous level, and 
then to add back single Cdh1 targets by introducing undegradable alleles expressed at 
endogenous levels, allows accurate dissection of the mechanism of action of even a 
highly pleiotropic regulator such as Cdh1.  In the case of bud morphogenesis, the 
situation is simple: the hyperpolarized bud phenotype is essentially due to a single target, 
Clb2.  Spindle morphogenesis is clearly much more complicated, but nevertheless, we are 
able to implicate mitotic cyclins as major regulators sufficient for significant spindle 
morphogenesis in the absence of other Cdh1 targets.  It may be possible through 
restoration of Cdh1-resistant targets such as Clb3 and Ase1 to permit mitosis in the face 
of constitutive APC-Cdh1 activity, thus defining a (not necessarily unique) set of 
essential Cdh1 targets.  More generally, with appropriate variations, this strategy should 
be applicable to dissection of the action of other complex regulators.   
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CHAPTER THREE 
Dissection of Cdh1 multisite phosphorylation 
 
Recombinational strategy to create partially phosphorylatable alleles of CDH1 
A variant on the recombinational strategy used to introduce CDH1-m11 into the 
chromosome (Chapter 2) was designed to introduce exact untagged chromosomal gene 
replacements of CDH1 alleles mutated for varying subsets of phosphorylation sites.  
Specifically, an allele pair comprised of cdh1-m11 and cdh1, each rendered non-
functional by insertion of different selectable markers at different positions, were 
arranged in tandem at the endogenous locus in both possible orientations (Figure 3.1).  
The URA3 gene is placed between the two cdh1 copies, so that FOA-selected ‘popout’ 
homologous recombination will result in the isolation of CDK phosphorylation site 
mutants, ablating contiguous sites beginning at either the N or C terminus of CDH1 
dependent on whether the 5' or 3' allele was the CDK-unphosphorylatable CDH1-m11 
(Figure 3.1A).  
 
Isolation of partially phosphorylatable CDH1 alleles  
In a wild-type background, the yield of recombinants ablating the N-terminal sites 
was reduced compared to expectations from physical distance (Figure 3.1B).  
Recombination occurs readily within this same interval to recreate a wild type CDH1 
allele.  Similarly, recombination is in direct proportion to physical distance if the tandem 
alleles are constructed so all possible products are interrupted (see Figure 2.2).  The  
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Figure 3.1 Recombinational approach to obtain CDH1 partial phosphorylation mutants. 
A Recombination based strategy used to obtain N-terminal (top) and C-terminal (bottom) 
partially phosphorylatable alleles as an exact gene replacements.  Horizontal bracket 
indicates region of recombination that results in an uninterrupted exact gene replacement.  
B Percentage of recombinations of the loci from (A) occurring within the region marked 
by the horizontal bracket, determined by loss of selectable markers.  CDH1 strain were as 
in (A) except the locus contained two tandem wild type CDH1 alleles.    
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distributional shift away from functional alleles was weaker for the C-terminally ablated 
sites, providing an initial suggestion that the N-terminal sites are particularly important in 
regulating CDH1 activity (Figure 3.1B).   
Further, sequencing of viable recovered N-terminal mutants showed that all 
clones had less than four phosphorylation sites ablated.  Given the proximity of the fourth 
site to the TRP1 marker, the expectation from the physical distance is that most N-
terminal recombinants should have at least four sites ablated.  However, clones with 
fewer than the expected minimal three sites were frequent, likely from gene conversion 
since in some cases the wild-type sites were interspersed between mutant sites.  Such 
events are presumably rare, and likely reflect selection against N-terminal mutations.   
Recovered viable C-terminal mutants revealed little or no such bias.  This suggested that 
the N-terminal sites have a greater weight in inhibiting Cdh1 activity, with N-terminal 
mutations being highly deleterious.  
Exact gene replacement with the lethal CDK-unphosphorylatable CDH1-m11 
allele was obtained in a cdc23-1 background hypomorphic for the APC (see Chapter 2).  
Therefore, we repeated the construction of partially phosphorylatable CDH1 alleles in a 
cdc23-1 background.  Recombinant CDH1 alleles were obtained at frequencies higher 
than those in CDC23 strains, although still reduced as compared to physical distance or 
the control recombination.  The reason for this is unclear, although poorer homology 
owing to the mutations ablating the phosphorylation sites on one of the alleles may be 
contributory.  The ratio of N-terminal mutants obtained in a cdc23-1 background is 
roughly threefold higher than with a wild type APC, whereas C-terminal mutants are 
nearly at parity (Figure 3.2A).  Sequencing revealed N-terminal mutations ranging from 3 
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to 11 sites, and C terminal mutations ranging from 0 to 8 sites (Figure 3.2B).  As with 
CDH1-m11, this argues that the decreased recovery of some of these strains in a CDC23 
background was the consequence of aberrant APC activation.  
 
Inviability of CDH1 mutants defective for N-terminal phosphorylation sites is APC 
dependent and suppressible by conditional ACM1 overexpression 
The CDH1 alleles obtained in cdc23-1 cells (see Figure 3.2B) were crossed into a 
CDC23 GAL1pr-3FLAG-ACM1 (‘GAL-ACM1’) background, so that the effects of these 
alleles in the context of a wild type APC could be observed (see Chapter 2).  Viability of 
strains with partially phosphorylatable CDH1 alleles was assessed by shutoff of ACM1 
expression (Figure 3.3A).  In the N-terminal series, CDH1-4N was the least 
phosphorylatable construct compatible with viability, whereas none of the C-terminal 
mutations including the maximal CDH1-8C noticeably impaired colony formation.  The 
morphology of these cells at six hours after GAL-ACM1 shutoff was assessed by DIC 
microscopy (Figure 3.3B).  Viable strains were predominantly morphologically normal; 
inviable strains displayed hyperpolarized growth similar to that found in CDH1-m11 
strains (see Chapter 2). 
We analyzed growth rates, Clb2 levels, and DNA content for viable CDH1 mutant 
cells in the absence of ACM1 overexpression.  The N terminal mutants CDH1-3N and 
CDH1-4N strains had lower cycling Clb2 levels, and slightly longer doubling times; C-
terminal mutant cells were similar to wild-type (Figure 3.4A, B).  DNA content, assessed 






Figure 3.2   The hypomorphic APC subunit allele cdc23-1 allows for isolation of a wide 
range of partially phosphorylatable CDH1 recombinants.  A cdc23-1, which is permissive 
for CDH1-m11 (see Chapter 2), increases the recovery of N-terminally but not C-
terminally mutated CDH1 alleles relative to CDC23 strains.  B CDH1 phosphorylation 
site mutant alleles obtained in a cdc23-1 background.  Circles represent putative CDK 











Figure 3.3 CDK regulation of CDH1 does not work by a strict counting mechanism. A 
Tenfold dilutions of the indicated alleles of CDH1 (exact gene replacements) all with 
GAL-ACM1 were grown in galactose medium and plated onto glucose or galactose-
containg plates.  B Strains from (A) were grown in galactose, shifted to glucose media for 








Figure 3.4 Phenotype of CDH1 alleles compatible with viability A Strains with the 
indicated CDH1 alleles (those resulting in strains viable in the absence of ACM1 
overexpression), were grown to log phase in glucose and Clb2 levels determined by 
western blot, using Pgk1 as a loading control (left). Graph on right quantifies immunoblot 
intensity, column names indicate the specific CDH1 allele. B Growth rates of the strains 
from (A) were measured C FACS to assess DNA content was performed on the strains in 
(A)  
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N-terminal mutants display synthetic interactions with S-phase cyclins 
 
The kinase(s) responsible for inactivating Cdh1 in late G1/S phase remain 
unclear, and arguments have been made for Clb3, 4, 5 and G1 cyclins playing a 
significant role in the inactivation of APC-Cdh1 (see Introduction).  We first sought to 
test for genetic evidence of S-phase cyclin contribution to Cdh1 inactivation.  We 
introduced the various partially phosphorylatable alleles into a clb5 clb6 GAL-ACM1 
background, and then tested for viability upon GAL-ACM1 shutoff.  The logic of this 
approach is that if Clb5/6 are uniquely responsible for phosphorylating some site(s), then 
the absence of Clb5/6 should phenocopy the lack of those sites.  For example, if Clb5/6 
uniquely phosphorylate the C-terminal sites, then the CDH1-4N mutant should cause 
inviability in a clb5,6 background because it is equivalent (with respect to Cdh1 
phosphorylation) to the completely unphosphorylatable and lethal CDH1-m11.   
CDH1-4N strains were inviable in the absence of CLB5/6, whereas there was no 
obvious loss of viability of CDH1-7C cells (Figure 3.5), consistent with the hypothesis 
above.  When tested with individual cyclin deletions, the predominant synthetic 
interaction was with CLB5; clb6 CDH1-4N strains were viable independent of Acm1 
overexpression (Figure 3.5).  This argues genetically for an interaction between CLB5 
and CDH1, possibly a direct one in which Clb5 phosphorylation serves to inhibit Cdh1 
activity, and in the absence of the N-terminal 4 sites, C-terminal Clb5-dependent 
phosphorylation of Cdh1 becomes essential.  This suggests that Clb5 is particularly 
important for phosphorylation of some or all of the remaining 7 C-terminal sites to 
effectively restrain APC-Cdh1 activity (although other interpretations are possible), and 













Figure 3.5 Synthetic interactions between S-phase cyclins and CDH1 phosphorylation 
mutants. CDH1-4N but not CDH1-7C strains are dependent upon CLB5 for viability.  
Tenfold dilutions of strains of the indicated genotypes, all with GAL-ACM1 were spotted 
onto glucose or galactose plates.  
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Preliminarily, inviable cells in this experiment display the typical high Cdh1 
activity phenotype with hyperpolarized growth characteristic of CDH1-m11 exact gene 
replacement.  clb5 clb6 CDH1 strains display modestly hyperpolarized growth relative to 
wild type (data not shown); this may be due a decrease in the ability to inhibit APC-Cdh1 
activity on the N-terminal sites and/or a delay in the inactivation of the G1 regulon 
(which is Clb-CDK dependent). 
In contrast, CDH1-4N clb3 clb4 and CDH1-7C clb3 clb4 strains were found to be 
viable (data not shown), suggesting that Clb5/6 may be more significant in Cdh1 
inhibition than Clb3/4.  This could be consistent with the earlier expression of Clb5/6 
than Clb3/4, or could reflect intrinsic substrate preference of Clb5/6 for Cdh1.  It could 
also reflect the ability of Cdh1 to proteolyze Clb3/4 but not Clb5/6, so that Clb5/6 are 
‘immune starters’ for Cdh1 inactivation.   
 
Acm1 is essential to block activity of partially phosphorylated Cdh1  
Three regulatory mechanisms have thus far been described for CDK-coupled 
inhibition of Cdh1 activity: CDK phosphorylation directly inhibiting the biochemical 
interaction of Cdh1 with the APC, CDK causing the nuclear export of Cdh1 by the Msn5 
transporter, and lastly binding of Cdh1 to Acm1, which precludes APC interaction; this 
mechanism interacts with CDK activity not through Cdh1 phosphorylation but rather 
through regulated degradation and localization of the Cdh1 inhibitor Acm1 (Enquist-
Newman et al., 2008; Hall et al., 2008; Martinez et al., 2006).  To test whether blocking 
specific phosphorylation sites in Cdh1 revealed specific interactions with these pathways, 
the various alleles were placed in an acm1 MSN5, ACM1 msn5, or acm1 msn5 
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backgrounds.  Deletion of ACM1 alone results in no obvious phenotype (Martinez et al., 
2006); msn5 deletion has pleiotropic effects owing to its role in nuclear transport, but 
MSN5 is not essential (Akada et al., 1996; Kaffman et al., 1998).  acm1 msn5 cells are 
viable and morphologically normal. 
ACM1 becomes essential in the context of N-terminal phosphorylation site 
ablations (Figure 3.6A).  CDH1-4N cells were inviable in the absence of ACM1, while 
CDH1-7C acm1 cells were fully viable.  Deletion of MSN5 was found to act as an 
enhancer of several acm1 CDH1-phosphomutant phenotypes (see Figure 3.7), but was 
not itself synthetically lethal with any partially phosphorylatable CDH1 allele.   
These results suggest a regulatory hierarchy, with CDK phosphorylation of N-
terminal sites and then C-terminal Cdh1 sites, Acm1 inhibition and Msn5-dependent 
nuclear export in decreasing order of importance. 
 
Genetic interactions between the Four N-terminal Cdh1 sites and ACM1 
The synthetic lethality between CDH1-4N and acm1 led us to analyze the first 
four sites in greater detail.  No single site was essential in the absence of ACM1 and/or 
MSN5 (Figure 3.6B). Combinations of mutations of the N-terminal 4 sites varied from 
strict dependence upon endogenous ACM1, to full viability even in an acm1 msn5 
background (Figure 3.7).  Some were viable in an acm1 but not an acm1 msn5 
background, indicating an ancillary or potential role for Msn5 regulation.  Each 
individual site had phenotypic consequences to its mutation in some assay, implying that 
these 4 potential sites can all actually be phosphorylated, with regulatory consequences.  





Figure 3.6 Strains lacking N-terminal phosphorylation sites of CDH1 are dependent upon 
ACM1 for viability, but no individual site is essential A CDH1-4N but not CDH1-7C 
strains are dependent upon ACM1 for viability. Tenfold dilutions of strains of the 
indicated genotypes, all with GAL-ACM1, were spotted onto glucose or galactose plates. 
B acm1 strains are not dependent upon phosphorlyation on any single specific site for 
viability.  Tenfold dilutions of strains of the indicated genotypes, all with GAL-ACM1, 














Figure 3.7 Synthetic interactions of the first four CDH1 phosphorylation sites with acm1 
and msn5.  Assessed by tenfold dilution assays in GAL-ACM1 containing strains. CDH1 
allele plated is indicated in left column.  Table qualitatively summarizes the synthetic 
lethalities, with CDH1 genotype on the x axis. ‘+’ is fully viable, ‘+/-’ is intermediate 
ability to form colonies, and ‘–’ is strictly inviable on glucose. 
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Analysis of strains with partially unphosphorylatable Cdh1 by time lapse 
microscopy  
The dependence of partial site mutants on normally dispensable regulatory 
machinery suggested that strains with these mutations might exhibit sporadic severe cell 
cycle problems, despite the absence of a severe bulk culture phenotype.  The logic of this 
idea is that fully phosphorylatable Cdh1 is protected with high redundancy, and 
occasional failure of complete phosphorylation could be compensated by high Acm1; 
conversely, occasional low Acm1 levels would be benign because of usually efficient 
Cdh1 phosphorylation.  The partially phosphorylatable versions have lost one of these 
safety mechanisms and so might reveal defects stochastically within a culture. 
To test this, we employed time-lapse quantitative fluorescent microscopy, using 
the nuclear marker HTB2-mCherry as well as a functional GFP-Clb2 fusion protein, 
which is degraded by Cdh1.  In all strains, most cell cycles were normal, with progression 
through mitosis and accumulation and removal of Clb2 occurring with normal dynamics.  
Approximately 3% of wild type CDH1 and 5% of CDH1-7C strains displayed abnormal 
mitoses, invariably of the form of a delay at a stage with a bilobed nucleus and relatively 
high Clb2-GFP, most of which eventually completed anaphase during the imaged period.  
Previous experience with such sporadic blocks in time-lapse microscopy of wild-type 
cells suggests that they are due to DNA damage, possibly induced by illumination for 
GFP detection (Bean et al., 2006). 
CDH1-4N strains had a significantly higher frequency (24%) of aberrant cell 
cycles.  These were heterogeneous, including arrests of the type noted above and also 
sequential aberrant mitoses (including abortive mitoses without nuclear division, mitoses 
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with very low accumulation of Clb2, and multibudded mitoses with nuclei passing 
through three cell bodies (see Figure 3.8B for example)).  
 
Discussion 
Recombinational construction of an exact gene replacement series of mutants 
 We describe a novel approach to creating a series of exact gene replacements, 
useful for the creation and analysis of intermediately modified forms of genes with 
numerous known modifications. It allows for the inference of modifications that are 
selected against, as well as efficient recovery of a diversity of viable mutants.  In our 
case, eleven intermediately phosphorylatable alleles of CDH1 were created by 
homologous recombination.  The nature of this allelic construction precludes the 
possibility of altered gene function owing to the presence of alternate exogenous 
sequences, selection markers, flanking vector sequences, or an otherwise modified 
chromosomal milieu, and is thus advantageous for the reasons discussed for the CDH1-
m11 exact gene replacement.   
 
Cdh1 inhibition cannot be reduced to counting phosphorylations 
Multisite phosphorylation in the stoichiometric B-type cyclin inhibitor Sic1 
appears to work by a strict counting mechanism, whereby six site need to be 
phosphorylated to be targeted for degradation by SCF-Cdc4 (Nash et al., 2001).  Given 
the prevalence of multisite phosphorylation, it is important to determine if this conclusion 
is general.  In Sic1, there is a clear distinction in efficiency and strength of the different 
phosphorylation sites, but this does not alter the general requirement for six sites (Nash et 
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al., 2001; Petroski and Deshaies, 2003; Verma et al., 1997).  Cdh1 functionally overlaps 
with Sic1, in that it opposes mitotic B-type cyclins from late anaphase through the 
subsequent G1.  However, our evidence argues against a counting mechanism regulating 
Cdh1 activity, since ablation of 8 C-terminal sites is viable without any discernible 
phenotype, whereas ablation of 3 or 4 N-terminal sites results in a discernible phenotype, 
and ablation of 7 is incompatible with viability. One obvious concern would be that the 
‘phosphorylation sites’ ablated are not actual kinase substrates in vivo, and thus of little 
physiologic relevance.  However, previous mass spectroscopic date places five of the six 
conclusively demonstrated phosphorylated sites among the 8 C-terminal sites that are not 
essential (Hall et al., 2004), and our genetic data clearly imply that all of the N-terminal 
sites are also phosphorylated (see above).   
 
No single CDK site on Cdh1 is essential 
Previous studies of the phosphorylation sites of Cdh1 have been restricted to a 
single allelic series ablating phosphorylation sites starting from the N-terminus, placed 
under a partial GAL promoter.  It was not possible to infer from this result whether one 
particular site beyond the first site is in fact essential to prevent the activation of Cdh1.  
Here, we find that there is not any one specific site that necessarily must be 
phosphorylated by CDK, as both the CDH1-4N and CDH1-8C alleles are viable in the 
presence of a fully functional APC.  There are also not any two adjacent sites which 
necessarily must be phosphorylated for viability, which could be relevant for some 








Figure 3.8 Single cell time lapse imaging of CDH1 mutants A Phase images of 
microcolonies formed by cells of the indicated genotypes.  Note CDH1-4N strain ability 
to form both morphologically normal and aberrant cells, a property not found in CDH1 or 
CDH1-7C. B  Aberrant mitoses in CDH1-4N cells.  Time lapse imaging of GFP-Clb2 
(green) and Histone-mCherry (red) marking the nucleus.  Yellow arrow points to a 
hyperpolarized cell which initially fails to undergo nuclear divison, and subsequently 
rebuds and divides its nucleus between three cell bodies. 
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N-terminal and C-terminal Phosphorylation sites are functionally distinct  
 Ablation of three or four N-terminal sites resulted in lowered cycling Clb2 levels 
and slightly slowed growth.  CDH1-4N cells were dependent upon endogenous ACM1 for 
viability, and CDH1-4N acm1 cells arrest similarly to CDH1-m11 ACM1 cells.  
Additionally, a minority of CDH1-4N cells demonstrated characteristics consistent with 
an inability to restrain APC-Cdh1 activity, including hyperpolarized growth, low GFP-
Clb2 accumulation, and aberrant nuclear separation, similar to that seen in CDH1-m11 
strains but not in CDH1 or CDH1-8C strains.   
 
Implications for specific CDK inhibition of APC-Cdh1 activity 
The G1 cyclins Cln1,2,3, and the early-expressed B-type cyclins Clb5, and Clb3/4 
have been reported to be responsible for inhibitory phosphorylation of Cdh1.  We 
explored the possibility that ablation of a subset of contiguous sites would result in the 
remaining sites dependent upon a specific class of cyclins for inhibitory phosphorylation.  
Consistent with an important role for Clb5 in inactivating Cdh1, CDH1-4N strains are 
dependent upon CLB5 for viability.  CLB6 has weaker genetic interactions, consistent 
with a less central role in CDH1 inhibition.  We do not find strong synthetic interactions 
between the tested CDH1 alleles and the early mitotic cyclins CLB3 and CLB4.  Genetic 
tests with G1 cyclins have not yet been performed. 
 
Nuclear Export of Cdh1 may play an ancillary role in regulation  
 CDK phosphorylation both blocks biochemical association of Cdh1 with the APC 
and promotes its nuclear export, which may sequester it from nuclear targets.  Different 
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sites could be responsible for these two actions.  This idea results in the following genetic 
prediction: if mutation of some Cdh1 sites resulted in constitutive APC activation, but 
Msn5 interacted with a different set of sites for nuclear export, and this export was 
sufficient to restrain Cdh1, then deleting MSN5 and mutating these sites in combination 
should be lethal.  To test this we crossed all partially phosphorylatable Cdh1 alleles to an 
msn5 strain, and found that none of them were dependent on MSN5 for viability.  This 
argues against nuclear export being a critical regulator of Cdh1 activity.  We were thus 
not able to find a partially phosphorylatable allele of Cdh1 which was critically 
dependent upon Msn5, suggesting that there was no partially phosphorylatable allele 
created that was exportable from the nucleus but which would otherwise constitutively 
activate the APC.  This result does not support the ability of Msn5-dependent transport to 
strongly restrain Cdh1 activity, although we obviously did not test all 211 combinations of 
sites, and it also could be that identical sites are responsible for regulating interaction 
with both the APC and Msn5.  Still, Msn5 nuclear export can contribute to Cdh1 
inhibition, as shown by an MSN5 requirement in acm1 strains mutated for some Cdh1 
CDK sites.  Further experiments are planned to test this directly (see future directions). 
 
General implications for regulation by multisite phosphorylation 
 Here we present an analysis of the relative contributions of subsets of 
phosphorylation sites for the core cell cycle regulator Cdh1.  S-phase cyclins and ACM1 
are essential for the viability of cells carrying specific CDK-unphosphorylatable CDH1 
alleles as exact gene replacements.  We infer the sites to be partially redundant, but 
phosphorylation of at least some (non-unique) subset of the sites is essential.  We do not 
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find evidence for a strict counting mechanism, as has been seen with Sic1 (Deshaies and 
Ferrell, 2001), nor clearly separable functions as evident in Pho4 (Komeili and O'Shea, 
1999).  Rather, we seem to find differing phosphorylation sites to have marginal effects 
of differing magnitudes.  It could be that parsing out the contributions of individual 
site(s) to Msn5 interaction or APC interaction would reveal a more specific pattern than 
can be seen so far just examining mutant viability in wild-type or compromised 
backgrounds.  It could also be that much of the effect of Cdh1 phosphorylation comes 
from bulk electrostatic effects with some regional specificity, a proposed pattern in many 
cases of multisite phosphorylation (Holt et al., 2009). 
 
Future Directions 
This work offers insights into the regulation of Cdh1 by multisite 
phosphorylation, but much remains to be done.   
Testing for synthetic interactions with G1 cyclin deletions may offer insights into 
the regulatory architecture of Cdh1.  The cln1 cln2 double mutant is viable, and often 
display defects owing to lack of G1 cyclins such as failure to bud (Skotheim et al., 2008),  
If G1 cyclins are solely responsible for the inhibitory phosphorylation of Cdh1 on a 
genetically separable subset of CDK sites, in the presence of CDH1 allele possessing 
only these sites it is possible that a cln1 cln2 mutant, with lowered G1 cyclin activity, will 
result in unrestrained Cdh1 activity preventing adequate accumulation of mitotic cyclins.   
 One implication of the present study is that nuclear export by Msn5 is not a 
critical regulator of Cdh1 activity.  The construction of GFP-tagged partially 
phosphorylatable alleles will allow for direct assessment of localization and possibly the 
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determination of sites responsible for nuclear localization; subsequent work could 
determine if any such site(s) are also required for regulation of direct Cdh1-APC 
interaction.   
A more detailed characterization of the arrest phenotype of cells lacking greater 
than 4 N-terminal phosphorylation sites—specifically CDH1-7N, 9N, and 10N—will 
reveal whether these alleles result in arrests with graded levels of Clb2, or whether either 
cyclins or Cdh1 ultimately prevails.  The prevalence, activity and significance of partially 
phosphorylated Cdh1 species during the cell cycle is not known, and the behavior of 
these alleles may offer insights into the nature of such species.  If all less 
phosphorylatable alleles result in similarly low Clb2 levels, the implication is that a 
marginal phosphorylation event may result in a sharp transition in APC-Cdh1 activity—
that is, in the absence of complete inhibitory phosphorylation, APC-Cdh1 may simply be 
fully on.  If graded decreases in Clb2 levels are found, this may be suggestive of either 
graded APC-Cdh1 activity in individual cells or stochastic but binary APC-Cdh1 activity 
in a bulk population.  Such stochastic switch-like APC activity has been observed with 
fzr, the Drosophila CDH1 homolog: analysis of increasingly weak alleles revealed a 
corresponding increase in the fraction of epidermal cells displaying unscheduled high 
level reaccumulation of mitotic cyclins; this result contrasts with the linear expectation of 
steadily increasing intermediate levels, and is suggestive of a dynamic relationship.  
Quantitative single cell time lapse microscopy will allow us to look for bistability by 
measuring GFP-Clb2 levels in individual arrested cells with partially phosphorylatable 
CDH1.  If APC-Cdh1 activity is strictly bistable, and all alleles incompatible with 
viability are constitutively active, then both the terminal GFP-Clb2 level, and the 
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progression to that level, ought to be the same in the context of the various alleles.  In the 
case of stochastic inactivation, it is possible that the fraction of cells with high level GFP-
Clb2 will correlate with the number of remaining phosphorylatable residues on Cdh1; the 
mechanism for such a high CDK level arrest in this context would have to be determined.  
Alternatively, if APC-Cdh1 activity is graded in individual cells, then intermediate levels 
of GFP-Clb2 may be observable which are sufficient to maintain phosphorylation of 
remaining Cdh1 sites so as to sustain graded APC activity, but insufficient for proper 
mitotic progression. 
Time lapse microscopy will also allow us to infer the APC dynamics of single 
cells with partially phosphorylatable CDH1 alleles.  This has been done preliminarily: 
sporadic cytologically aberrant mitoses were observed in CDH1-4N cells, frequently 
associated with very low Clb2-GFP levels.  Precise measurements may allow for an 
assessment of whether individual cells either have delayed APC-Cdh1 inactivation in late 
G1 or premature activation during mitotic exit as indicated by shifts in the GFP-Clb2 
trace; such a result would be consistent with APC-Cdh1 switch-like behavior, in which 
removal of potential phosphorylation sites biases the switch to the ‘on’ position.  It is also 
conceivable that timing will be essentially unaltered but peak GFP-Clb2 levels damped, 
which would imply a graded activity of partially phosphorylated Cdh1.  In this way, the 
analysis of single cells may allow for inferences into the regulatory architecture of Cdh1 
multisite phosphorylation.   
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CHAPTER FOUR 
Regulated degradation of the APC coactivator Cdc20 
 
Temporal separation of APC-Cdc20 and APC-Cdh1 activity is thought to promote 
ordering of degradation of APC substrates (see Introduction).  Not only must Cdh1 
activity be restrained until mitotic exit (see Chapter 2), but it is likely that Cdc20 must be 
inactivated for the subsequent cell cycle.  Inability to inactivate Cdc20 would impede 
securin accumulation, impairing separase regulation, and constitutive Cdc20 could also 
block accumulation of the major S-phase cyclin Clb5. 
Three mechanisms are known to contribute to Cdc20 inactivation: the 
dephosphorylation of the APC (Kramer et al., 2000; Rudner and Murray, 2000), 
transcriptional shutoff (Prinz et al., 1998), and the destruction of Cdc20 itself (Prinz et 
al., 1998; Shirayama et al., 1998; Weinstein, 1997).  The following is an attempt to 
clarify the literature with regards to the regulated destruction of Cdc20.   
 
Destruction boxes of Cdc20 both contribute to its degradation 
 Cdc20 has two destruction boxes thought to target it for destruction (Shirayama et 
al., 1998).  It has been argued based on the stabilization of overexpressed alleles deleted 
for the region containing destruction boxes that both destruction boxes contribute to 
Cdc20 degradation in G1 (Prinz et al., 1998; Shirayama et al., 1998).   One study also 
found residual APC-dependent but destruction-box independent Cdc20 instability 
throughout the entire cell cycle (Prinz et al., 1998). Another study argued that 
degradation of Cdc20 was dependent only on the first destruction box (Goh et al., 2000), 
 79
and was cell-cycle-regulated (highest in G1), but was independent of APC activity.  
These substantially contradictory results hamper understanding of this potentially 
important regulatory event. 
We sought to test the consequences of removing Cdc20 destruction boxes on 
protein stability through the ablation of either each destruction box individually, or both 
simultaneously, in the context of the endogenous locus and promoter.  This is in contrast 
to all previous work on Cdc20 destruction box function, which was carried out with 
overexpression.  An 18-myc tag was placed at the N-terminus so that protein levels could 
be followed, and the destruction box consensus site RxxL was mutated to AxxA so as to 
prevent APC engagement of the destruction box without possible inadvertent 
consequences from deletions, as were used in much previous work (Figure 4.1).  CDC20-
db1 ablates the first destruction box, CDC20-db2 the second, and CDC20-db3 both.  
These alleles were fully functional, as they replaced the endogenous copy of CDC20, 
which is an essential gene.  Additionally, they were also viable in the absence of CDH1, a 
genetic background known to be sensitive to hypoactive APC-Cdc20 (Cross, 2003).  
Cells were synchronized in α-factor and released, with Myc-Cdc20 accumulation 
monitored by western blotting against Myc (Figure 4.2).  Both destruction boxes 
contributed to Cdc20 degradation, and the effects of mutating both of them were 
significantly greater than the mutation of either one alone.  
Cdc20 protein levels remained cell cycle regulated even with mutated destruction 
boxes.  The Cdc20 destruction boxes were required for clearance of Cdc20 in α-factor 
blocked cells (most clearly seen with the double db mutant Cdc20-db3).  Cdc20-db3 















Figure 4.1 Schematic of Cdc20 and destruction box mutants.  Two destruction boxes are 
found in the N-terminus (DB1 and DB2), with DB1 neighboring a potential CDK site of 
unknown function.  The alanine substitutions ablating these destruction boxes in the 








Figure 4.2 Destruction boxes contribute to, but are not solely responsible for, the 
destruction of Cdc20. Strains bearing 18MYC-tagged CDC20 with either destruction box 
1 (db1), destruction box 2 (db2), or both destruction boxes (db3) ablated were 
synchronized with α-factor and released.  Immunoblots against Myc are shown, with 
Pgk1 serving as a loading control. 
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higher peak level around the time of mitosis.  (A similar effect was detectable with wild-
type Cdc20, despite the extremely low initial levels which presumably resulted from 
efficient destruction-box-dependent proteolysis.)  CDC20 transcription is low at α-factor 
arrest, and only increases late in the cell cycle (Spellman et al., 1998); thus, the decline in 
Cdc20 levels shortly after release from the α-factor block is probably not the consequence 
of transcriptional downregulation.  Rather, Cdc20 appears to be actively destroyed by 
some process as cells progress through G1 into S.  This degradation is destruction box-
independent, and is unlikely to be APC-Cdh1 mediated, as Cdh1 activity is very high in 
α-factor-blocked cells and declines upon release.   
To allow for direct comparison of Cdc20 levels from the α-factor release, 
identical time points were loaded on the same gel to avoid gel-to-gel variability in 
intensity.  The destruction box dependent degradation in α-factor was confirmed (Figure 
4.3A).  Interestingly, the destruction boxes had no effect on Cdc20 at 40 minutes and 80 
minutes after release; at 120 minutes post-release destruction box-dependent degradation 
became apparent based on higher Cdc20 levels in the absence of destruction boxes. 
 Overexpression of CDC20 lacking destruction boxes has been reported to 
interfere with S-phase progression (presumably mediated through sustained APC-Cdc20 
ubiquitination of the S-phase cyclin Clb5)   (Huang et al., 2001).  However, with CDC20-
db3 expressed at endogenous levels we observe no S-phase or division delay (Figure 





Figure 4.3 Ablation of destruction boxes particularly stabilizes Cdc20 in α-factor, but 
does not affect DNA replication kinetics. A Samples from Figure 4.2 for each CDC20 
allele at indicated timepoints were loaded next to one another on the same gel and blotted 
against.  B FACS analysis of DNA content from samples taken in parallel with those 
from Figure 4.2.  No differences are discernible with respect to progression through S-
phase, or at other points, amongst the different CDC20 alleles. 
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Overexpression of CDH1 fails to clear Cdc20 
 APC-Cdh1 activity has been reported to restrain Cdc20 accumulation until early 
S-phase (Huang et al., 2001). We found Cdc20 to be nearly completely removed in α-
factor-blocked cells, but this removal was only partially destruction-box dependent.  α-
factor-blocked cells contain high APC-Cdh1 activity, which could account for Cdc20 
clearance in these cells.  Therefore, we tested whether Cdh1 overexpression in cycling 
cells is able to clear Cdc20 expressed from the endogenous locus.  Overexpressed CDH1 
had little effect on Cdc20 levels, and while CDH1-m11 was able to reduce the level of 
Cdc20, this effect was incomplete even after two hours of CDH1-m11 induction (Figure 
4.4).  This time of induction of GAL-CDH1-m11 results in massive overexpression of 
Cdh1-m11 (Zachariae 1998a; data not shown).  This indicates that Cdh1, even when both 
overexpressed and highly active, is not capable of efficiently clearing Cdc20, and 
suggests that the effective clearance of Cdc20 in α-factor-blocked cells is due at least in 
part to Cdh1-independent activities.  
 
Cdc20 levels are increased but still cell cycle regulated in the absence of CDH1 
 We examined the effect of endogenous Cdh1 on Cdc20 levels.  Using centrifugal 
elutriation, we separated cycling cdh1 and wild-type cells into different cell cycle 
fractions based on cell size (this change in procedure was necessary because cdh1 cells 
fail to arrest properly in response to α-factor).  cdh1 cells have higher levels of Cdc20 
than CDH1 cells, particularly in G1; however, Cdc20 declines to a low level in cdh1 cells 
as they progress through S-phase (Figure 4.5), before increasing later in the cell cycle.  

















Figure 4.4 Overexpressed CDH1-m11 lowers Cdc20 levels, but does not clear it.  Either 
HA-CDH1 or HA-CDH1-m11 was induced using deoxycorticosterone in cycling strains 
with a GAL4-Mineralocorticoid receptor fusion (containing the DNA binding domain of 
the former, and ligand binding domain of the latter, rendering GAL responsive genes 
inducible by exogenous mineralocorticoids).   Levels of endogenously expressed 
18MYC-Cdc20 and HA-Cdh1 were followed by immunoblot, with a nonspecific band 













Figure 4.5 Deletion of CDH1 partially stabilizes Cdc20.  A CDH1 18MYC-CDC20 and 
cdh1 18MYC-CDC20 strains were elutriated, and the resultant fractions were 
immunoblotted for Myc and Clb2.  Pgk1 serves as a loading control. B FACS to assess 
DNA content for the fractions collected in (A) 
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involved in the degradation of Cdc20.  This finding correlates with the characterization 
above of destruction box-dependent and independent mechanisms of Cdc20 proteolysis. 
 
Inducible Cdc20 is degraded by both Cdh1- dependent and independent 
mechanisms 
 Depletion of Cdc20 results in a reversible metaphase arrest.  An allele of MET3-
HA-CDC20 replacing the endogenous copy of CDC20 allows for methionine-repressible 
CDC20 transcription; in the absence of methionine CDC20 is constitutively expressed.  
MET3-HA-CDC20 CDH1 and MET3-HA-CDC20 cdh1 strains were constructed and 
grown to log phase in media lacking methionine.  Methionine was then added, and 30 
minutes after addition strains did not have any detectable Cdc20 in either CDH1 or cdh1 
backgrounds (Figure 4.6).  cdh1 strains readily arrest in the first cycle after shutoff of 
CDC20 transcription, similar to CDH1 control cells.  Upon induction of CDC20 to 
release the cells, Cdc20 levels increase much more in a cdh1 than in a CDH1 
background, suggesting that APC-Cdh1 can effectively dampen Cdc20 levels during 
mitotic exit.  However, this effect is short lived, and Cdc20 rapidly stabilizes at a lower 
level (though still higher than CDH1 cells) (Figure 4.6).    
These results are consistent with the effects of CDH1 deletion on Cdc20 levels 
from the endogenous promoter, and on the effects of Cdc20 destruction box mutation, in 
demonstrating Cdh1- and db-dependent Cdc20 degradation, and independent degradation 









Figure 4.6 Inducible Cdc20 is degraded by both Cdh1 dependent and independent 
mechanisms. A Methionine was added at time 0 to cycling CDH1 and cdh1 strains, with 
MET3pr-HA-CDC20 (methionine repressible) replacing endogenous CDC20, to shutoff 
CDC20 transcription. After two hours, these cells were released into methionine-free 
media, inducing CDC20 transcription.  Samples were taken every ten minutes thereafter 
(R10, R20, etc).  HA-Cdc20 was immunoblotted against, with Pgk1 serving as a loading 
control.  B DNA content of the strains in (A) was assessed by FACS.  C Quantification of 
immunoblots in (A).   
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Discussion 
The regulatory control of Cdc20 has implications for the proper ordering of cell 
cycle events.  Multiple mechanisms are involved in its regulation including 
transcriptional control, Cdc20 protein destruction, and CDK phosphorylation of the APC.  
Both the transcriptional control and at least part of the CDK phosphorylation of the APC 
(specifically of Cdc16, Cdc23, and Cdc27) are dispensable for essentially normal cell 
cycle progression (Rudner and Murray, 2000; Yeong et al., 2001).  This work addresses 
the mechanisms by which Cdc20 protein stability is regulated, clarifying the agents, 
timing and motifs involved in Cdc20 destruction. 
Conflicting reports exist in the literature as to what mediates the destruction of 
Cdc20.  Studies have variously implicated the APC but presumably not Cdh1 (Prinz et 
al., 1998; Shirayama et al., 1998), APC-Cdh1 specifically (Huang et al., 2001), and an 
APC-independent mechanism (Goh et al., 2000).  Here we find evidence for both APC-
Cdh1 dependent and independent mechanisms.   
APC-Cdh1 effectively restrains Cdc20 levels from mitotic exit through the 
subsequent G1 (Figure 4.5).  This provides a simple mechanism for temporal separation 
of APC-Cdc20 and APC-Cdh1 activity, by Cdh1-dependent removal of Cdc20.  Other 
mechanisms, such as dephosphorylating core APC components, may also contribute.  
Beginning in late G1/early S, a Cdh1-independent mechanism is responsible for Cdc20 
degradation.  We speculate that this may play role in limiting Cdc20 accumulation prior 
to anaphase so as to prevent premature cohesin cleavage, or may contribute to efficient 
engagement of the spindle checkpoint during aberrant mitoses (since Cdc20 is the 
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ultimate target of this checkpoint).  The molecular basis for APC-Cdh1 independent 
degradation of Cdc20 is unknown.   
APC dependent but destruction box independent degradation of Cdc20 was 
reported in S phase and mitosis (Prinz et al., 1998); it is possible that this is the Cdh1- 
and destruction box-independent Cdc20 degradation we observe.  We have not evaluated 
the role of APC-dependent but coactivator-independent ubiquitination of Cdc20. 
 Work based upon overexpression studies of CDC20 alleles with destruction box 
deletions, has arrived at conflicting conclusions for the relative contributions of the two 
destruction boxes (Goh et al., 2000; Prinz et al., 1998; Shirayama et al., 1998).  We find 
both destruction boxes to contribute to Cdc20 instability, particularly during G1.  
However, the stabilization conferred by destruction box ablation appears only partial; 
peak mitotic levels of Cdc20-db3 are higher than α-factor blocked levels, while small G1 
elutriated cdh1 cells have similar Cdc20 levels to their large 2C DNA content 
counterparts.  This suggests that APC-Cdh1 mediates the destruction of Cdc20 through 
both destruction box dependent and independent mechanisms.  One possible targeting 
motif is a potential KEN box in the C-terminal portion of Cdc20; the contribution of this 
motif to Cdc20 instability has not been evaluated.   
This work, taken as a whole, argues for a Cdh1 and destruction box dependent 
mechanism targeting Cdc20 for destruction from late mitosis through the subsequent G1, 
and a separate Cdh1 and destruction box independent mechanism degrading Cdc20 from 
S-phase into mitosis.  The Cdh1 dependent degradation likely contributes to the strict 
alternation of APC-Cdc20 and APC-Cdh1 activity, thus promoting separate degradative 
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regimes during anaphase onset and spindle disassembly.  These findings go some way to 




Conclusions, Questions and Future Directions 
 
CDK phosphorylation and Acm1 regulate Cdh1 activity 
Through a careful exact gene replacement study, we have found CDK 
phosphorylation of Cdh1 to be essential for inactivating APC-Cdh1, and this inactivation 
essential for viability.  Acm1, which is not required for normal cell cycle progression or 
APC-Cdh1 inhibition, can block Cdh1 sufficiently to allow a fraction of cells to construct 
bipolar spindles, but not undergo anaphase or complete the cell cycle.  This establishes 
CDK phosphorylation as the major and essential regulator of APC-Cdh1 activity, and 
places Acm1 in a minor supporting role. We fail to find any evidence that Cdc5 
phosphorylation is able to inhibit Cdh1 activity.   
A failure of CDK phosphorylation of Cdh1 results in a predominantly monopolar 
spindle arrest.  SPB separation can be promoted by expression of an undegradable mitotic 
cyclin, but not the kinesin Cin8 as had been previously reported (Crasta et al., 2006).  A 
fraction of CDH1-m11 cells construct bipolar spindles, which nevertheless fail to 
progress to anaphase owing to a failure to accumulate Cdc20 and consequently to cleave 
cohesin.   
This approach has thus allowed for the determination of the physiologically 
significant regulators of Cdh1 activity, as well as mechanisms by which failure to 
inactivate Cdh1 interferes with cell cycle progression.   
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Does Acm1, in the absence of inhibitory CDK phosphorylation of Cdh1, permit 
bipolar spindle construction through mitotic cyclin accumulation? 
How Acm1 allows for bipolar spindle assembly in a fraction of these cells is not 
clear.  We find that increasing the gene dosage of ACM1 results in a corresponding 
increase in mitotic cyclin levels, and independently that expression of undegradable 
cyclins promotes SPB separation.  It is possible that a single copy of ACM1 allows for a 
fraction of cells to construct bipolar spindles by inhibiting the APC sufficiently to allow 
for at least transient accumulation of mitotic cyclins, which could drive bipolar spindle 
assembly.  If this is the case, then altering the copy number of CLB2, or replacing the 
endogenous gene with an allele coding for a partially stabilized cyclin such as with the 
KEN box ablated, would be predicted to increase the proportion of bipolar spindles seen 
at the CDH1-m11 arrest.  An alternate, but not mutually exclusive possibility is that the 
accumulation of other APC substrates contributes significantly to bipolar spindle 
assembly. 
 
Is there a physiological role for Cdh1 nuclear export? 
 The physiological role of nuclear export in Cdh1 regulation, if any, remains 
unclear and not easily addressed.  As Msn5, which exports Cdh1 from the nucleus, is not 
essential, it is unlikely that nuclear export is a critical inhibitor of Cdh1.  It is not known 
whether preventing nuclear export alters the CDH1-m11 terminal phenotype; it is 
conceivable that a shift towards monopolar spindle arrest would result from deletion of 
MSN5.  However, given the numerous other proteins shuttled by Msn5, such a result 
could also plausibly explained by pleiotropic effects. 
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 Cdh1 export is phosphorylation dependent (Jaquenoud et al, 2002), and 
experiments are planned to test whether specific partially CDK-unphosphorylatable Cdh1 
alleles are constitutively nuclear.  This will be performed with partially 
unphosphorylatable GFP-tagged Cdh1 alleles under the GAL1 promoter, which will be 
integrated into cells with HTB2-mCherry marking the nucleus.  By arresting the cells 
with α-factor, inducing GFP-Cdh1 alleles, and then releasing them, the Cdh1 nuclear 
export dynamics will be measured as they progress through the cell cycle.  If a specific 
site or cluster of sites is responsible for nuclear export, then alleles lacking such site(s) 
will be expected to be constitutively nuclear.  If specific sites are responsible, it will be 
interesting to see whether these same sites are also involved in blocking APC interaction.  
Alternatively, if nuclear export is based upon generic binding of CDK phosphorylation 
sites, all partially unphosphorylatable Cdh1 alleles will result in slowed nuclear export.   
 
Does Cdh1 drive its own inactivation through transcription? 
 As mitotic cyclins are responsible for turning off the G1 regulon (Amon et al., 
1993) and Cdh1 promotes mitotic cyclin degradation, a failure to inactivate Cdh1 likely 
results in sustained G1 regulon expression.  This is suggested by the sustained polarized 
growth found in CDH1-m11 cells.  In a normal cell cycle, Cdh1 inactivation likely 
involves the progressive phosphorylation of Cdh1 until it is inactivated.  If, for some 
reason, Cdh1 inactivation fails (such as by a stochastic failure to sufficiently 
phosphorylate it), persistent Cdh1 activity might prevent the shutoff of the G1 regulon.  
The result of this could be sustained transcription of proteins responsible for Cdh1 
inactivation, including the G1 cyclins, ACM1, and CLB5 (Spellman et al., 1998).  This is 
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testable through the use of reporters, such as fluorescent proteins placed under the control 
of these respective promoters, as well as by microarray analysis.  If this is the case, then 
ACM1 transcription alone is not sufficient to inactivate Cdh1; however the combination 
of Acm1 and the perhaps more important cyclins would likely be sufficient in the more 
physiological context of phosphorylatable Cdh1.  
 Of note, this mechanism could plausibly also drive PDS1 transcription (Spellman 
et al., 1998) if Cdh1 inactivation fails.  This would have the effect of preventing 
premature anaphase, especially if Cdh1 has some ability to ubiquitinate Pds1. 
 
Acm1 as a Cdh1 buffer 
 In the absence of Cdh1 phosphorylation, a single copy of ACM1 is insufficient to 
permit cell cycle progression.   However, it does allow a fraction of cells to separate their 
SPBs.  The induction of Acm1 in late G1, in the context of a normal cell cycle, may serve 
to buffer APC-Cdh1 which has not been inactivated.  If inactivation of Cdh1 by 
phosphorylation is delayed, it is plausible that the expression of Acm1 will allow for 
timely bipolar spindle construction and cell cycle progression. 
 
How does inhibitory multisite Cdh1 phosphorylation work?  
Multisite phosphorylation is a common but poorly understood regulatory 
mechanism; Cdh1, with its 11 putative CDK sites, is an excellent example of such 
multisite phosphorylation.  The principles by which such regulatory mechanisms 
function, and whether they can be generalized or simply categorized, remain largely 
unclear.  Numerous possibilities exist.  Distinct sites may mediate different regulatory 
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mechanisms.  Partially overlapping subsets of sites may mediate different regulatory 
mechanisms (Komeili and O'Shea, 1999).  Clusters of sites may determine regional 
electrostatics important for protein protein interactions (Holt et al., 2009).  Apparently 
strict counting mechanisms have been reported (Nash et al., 2001).  Only through the 
characterization of numerous proteins regulated by multisite phosphorylation can 
principles and predominant circuitry be inferred.  We have attempted to explore the 
multisite phosphorylation of Cdh1, and have made some progress.  We have found that 
no individual, nor two adjacent, phosphorylation sites are required.  Genetically separable 
alleles collectively covering all phosphorylation sites were found, with specific synthetic 
interactions found with N-terminal site ablation and the single deletions of ACM1 and 
CLB5.  N-terminal sites were found to contribute more significantly to Cdh1 inactivation 
than C-terminal sites.  These results preclude the interpretation of any strict counting 
mechanism.  Sites are genetically separable, which may in part reflect the specificity of 
inhibitory phosphorylation; we were not able to infer any strict separation of regulatory 
mechanisms.  Further characterization of nuclear localization determinants by the 
experiments outlined has the potential to shed further light on the underlying architecture 
of Cdh1 multisite phosphorylation.  This will undoubtedly need to be supplemented with 
precise biochemical studies. 
 
Temporally separating Cdc20 and Cdh1 activity 
 APC-Cdc20 and APC-Cdh1 act sequentially, helping to order anaphase and 
mitotic exit.  We have examined the regulatory mechanisms restraining Cdh1 activation 
in detail, as well as addressing open questions pertaining to the regulation of Cdc20.   Our 
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work on the regulation of Cdc20 argues for a Cdh1 and destruction box dependent 
mechanism targeting Cdc20 for destruction from late mitosis through the subsequent G1, 
and a separate Cdh1 and destruction box independent mechanism degrading Cdc20 from 
S-phase into mitosis.  The Cdh1-independent degradation may lower Cdc20 levels so as 
to prevent premature Cdc20 activation.  The Cdh1 dependent degradation of Cdc20 can 
directly contribute to the strict alternation of destructive phases, and may allow for Cdc20 
specific substrates to accumulate before Cdh1 is inactivated in late G1/S.   
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CHAPTER SIX 
Materials and Methods 
 
Yeast strains and plasmids. 
Standard methods were used throughout.  All strains are W303.  See Table 5.1 for 
strains used.  See Table 5.2 for plasmids used. 
 
Time Courses 
CDH1-m11 GALL-HA-ACM1 time courses were performed by arrest in YPG + 
10nM α-factor for 135 minutes at 30°, followed either by glucose addition or 
resuspension in YPD + 10nM α-factor for 30 minutes.  (Both procedures were found to 
result in complete clearance of exogenous Acm1 by western blot, and had identical SPB 
phenotypes.)  For time lapse microscopy, strains were washed 3X in SC media, placed 
onto SC + Glucose agar pads, and imaged as in (Bean et al., 2006), discussed below.  For 
bulk culture time courses, cells were removed from α-factor by 3 washes in cold YEP, 
and released into YPD at 30°C.  For fluorescent microscopy in these timecourses, cells 
were fixed at room temperature for 15 minutes using a 4% paraformaldehyde buffer, 
washed twice with Sorbitol-Phosphate buffer ((1.2M sorbitol, 200 μM MgCl2, 100 mM 
KPO4, pH 7.5)), and otherwise handled as in (Drapkin et al, Molecular Systems Biology, 
in press).   
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 MET3pr-CLB2-kd time courses were carried out similarly except that pregrowth, 
arrest and 60 min of release were carried out in 0.2g/L methionine (10X standard 
concentration). Transfer to methionine-free medium by three washes then induced 
MET3-CLB2-kd. 
Temperature sensitive scc1-73 and corresponding controls were blocked in α-
factor for 165 minutes at 23°, and glucose added for 30 minutes to inactivate GAL-
ACM1.  After 3 washes in ice-cold YEP, cells were released at 30° and shifted to 37° 30 
minutes post-release to inactivate scc1-73.   
 All other α-factor time courses were performed by blocking for between two and 
three hours in α-factor, washing 3X in α-factor-free media, and releasing into the 
indicated culture conditions.  Washing of α-factor arrested cells requires centrifugation; 
filtration leads to clumping of these cells.   
MET3-HA-CDC20 time courses were performed by adding 0.2g/L methionine to 
methionine-free synthetic media, arresting for between two and three hours, filtered onto 
nitrocellulose membranes, washed and release into methionine-free medium.  GALL-
CDC20 time courses were performed by centrifugation of log phase cells in YPG, 
washing, resuspension into YPD, arrest for two to three hours, 3X washing, and release 
into YPG.  GALL-CDC20 blocks requires resuspension into galactose-free media for the 
arrest; simple addition of glucose is inadequate for a clean arrest. 
 Centrifugal elutriations were performed using 1L of log phase culture with a 
Beckman JE5.0 elutriator rotor, running at 3000RPM with sequential fractions elutriated 
off by stepwise increase in pump speed.  
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Fixed cell fluorescence microscopy 
Fluorescence and DIC images were acquired using an Axioplan 2 microscope 
(Carl Zeiss MicroImaging Corp.) with a 63X 1.4 numerical aperture Plan- Apochromat 
objective, coupled to a Hamamatsu C4742-95 CCD camera (Sciscope Instrument). 
Camera and microscope were interfaced with the OpenLab software (Improvision). 
Filters and dichroics used were made by Chroma. YFP was detected with a YFP filter, 
mCherry with a Cy3 filter, CFP with a CFP filter, and GFP with a narrow band pass 
FITC filter.  For spindle analysis seven optical sections were taken at 0.3 micron spacing; 
for illustrative purposes these were merged into two-dimensional maximum projections.  
Acquisition was automated using an OpenLab script written by B. Drapkin. 
 
Time-lapse Microscopy 
Time-lapse microscopy was performed as described (Bean et al., 2006). Briefly, 
fields of single cells were imaged with fluorescence time-lapse microscopy at 30 °C 
using a Leica DMIRE2 inverted microscope with a Ludl motorized stage (Bean et al., 
2006). Images were acquired with a Hamamatsu Orca-ER camera. Custom Visual Basic 




Western Blots were performed using standard methods.  Antibody concentrations 
used were: anti-Pgk1 1:10,000 (Invitrogen), anti-HA 12CA5 1:1,000 (Roche), rabbit 
polyclonal anti-Clb2 1:10,000, Myc 9E10 1:1,000 (Santa Cruz Biotechnology), Clb5 yN-
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17 (Santa Cruz), Cdc5 yC-19 (Santa Cruz), and HRP-conjugated secondary antibodies at 
1:4,000.  ECL signal was measured in a Fujifilm DarkBox with CCD camera, and 
quantified using MultiGauge software (Fujifilm). 
 
Flow Cytometry 
 DNA content was assessed through propidium iodide staining of ribonuclease 
treated cells on a FACSCalibur machine (BD Biosciences), as described (Epstein and 
Cross, 1992). 
 
Quantitative PCR  
Quantitative PCR was performed using SYBR green (Qiagen) according to the 
manufacturer’s instructions, and data analyzed by SDS 2.2 (Applied Biosystems). 
 
Cloning: 
 CDC20, CDH1-pkm, and first four N-terminal CDH1 CDK site mutagenesis was 











CDH1-pbm was constructed by PCR, by creating separate overlapping fragments 








For JRP91 (pRS406 ACM1), ACM1 was cloned as a ClaI fragment and placed 
into pRS406 at the ClaI site. 406-HLP112 is HLP112 BglI swapped into pRS406.  For 
405-GALL-HLP109, HA3-ACM1 was cloned as an XbaI/XhoI fragment into a 405-
GALL plasmid backbone. 
For construction of Myc-tagged Cin8 alleles, an N-terminal 6MYC tag was 
subcloned out of pTK138 (6MYC-CIN8) via AgeI/PacI and into the corresponding 
region of pEH113, 250 and 394 (CIN8, CIN8-alaKEN, and CIN8-KED respectively) that 
had been BglI-swapped into a pRS406 backbone.  Resultant plasmids were transformed 
into the endogenous locus after PacI linearization, and clones screened to ensure presence 
of the 6MYC tag (which in principle can be lost in transformation due to resection past 
the tag prior to integration).   
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Table 5.1 (pages 104-108) 
Strain Name Genotype 
3023-2-1 MATa cdh1-m11::LEU2::URA3::cdh1-m11::TRP1 
3023-2-2 MATa cdh1-m11::TRP1::URA3::cdh1-m11::LEU2 
JRC35B-8d MATa cdh1-m11::LEU2::URA3::cdh1-m11::TRP1 cdc23-1 
JRC36B-5d MATa cdh1-m11::TRP1::URA3::cdh1-m11::LEU2 cdc23-1 
JRC374A-5b MATa GAL1-3FLAG-ACM1-URA3::ura3 ADE2 
JRC374C-3a MATa GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX ADE2 
MNX29-3b MATa CDH1-m11 GAL1-3FLAG-ACM1-URA3::ura3 
MNX29-8b MATa CDH1-m11 acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
JRC258B-9c MATa CDH1-pkm GAL1-3FLAG-ACM1-URA3::ura3 ADE2? 
JRC275B-11d MATa CDH1-pkm GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC362C-7c MATalpha CDH1-pbm GAL1-3FLAG-ACM1-URA3::ura3 
JRC373D-6c MATa bar1 CDH1-pbm GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC307C-2c 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 MYO1-mCherry::HIS3 
TRP1::CFP-TUB1  
JRC307A-2a 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 MYO1-mCherry::HIS3 TRP1::CFP-
TUB1  
JRC318A-9c 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-TRP1 
MYO1-mCherry::HIS3 ADE2 
JRC318A-11d 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 ade2 
JR313 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 ACM1::URA3 ade2 
JR314 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 4XACM1::URA3 ade2 
JR315 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 2XACM1::URA3 ade2 
330I-7b 
MATa bar1 GALL-HA3-ACM1::LEU2 SPC42-CFP::TRP1 HIS3::GFP-TUB1 MYO1-
mCherry::HIS3 acm1::KanMX 
395B-1b 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2  SPC42-CFP-TRP1 HIS3::GFP-
TUB1 MYO1-mCherry::HIS3 acm1::KanMX 
JRC430A-9a MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 18MYC-CDC20-TRP1 
JRC430A-5a MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 18MYC-CDC20-TRP1 
JRC431B-4a MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 PDS1-18MYC-LEU2 
JRC431D-4b MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 PDS1-18MYC-LEU2 
JRC389A-6d 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2HTB2-mCherry-HIS5 SPC29-
YFP-HIS3 CFP-TUB1-TRP1 MYO1-mCherry-HIS3 
JRC390A-5a 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2HTB2-mCherry-HIS5 SPC29-
YFP-HIS3 scc1-73 TRP+ ade2 
JRC304 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-TRP1 
MYO1-mCherry::HIS3 6MYC-CIN8::ura3::CIN8 ADE2 
JRC306 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-TRP1 
MYO1-mCherry::HIS3  6MYC-CIN8-alaKEN::ura3::CIN8 ADE2 
JRC301 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 6MYC-CIN8::ura3::CIN8 ade2 
JRC303 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3  6MYC-CIN8-db::ura3::CIN8-alaKEN ade2 
JR325 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 ade2 MET3pr-CLB2-kd::URA3 
JR326 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-TRP1 




MATa bar1 Clb2,kd trp1::TRP1::GAL1-SIC1(2X) HIS3:GFP-TUB1 SPC42-
CFP::TRP1 
JR393A-2d 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 trp1::TRP1::GAL1-SIC1(2X) 
CLB2-ken,db SPC42-CFP::TRP1 HIS3::GFP-TUB1 MYO1-mCherry::HIS3 
 
JRC344F-12d MATa bar1 CIN8-GFP::URA3 SPC42-CFP::TRP1 acm1::KanMX 
JRC312A-5b MATa bar1 CDH1-pkm CIN8-GFP::URA3 SPC42-CFP::TRP1 acm1::KanMX 
JRC406B-4b 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-TRP1 
MYO1-mCherry::HIS3 mad2::KanMX ade2 
JRC406C-4b 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HIS3::GFP-TUB1 SPC42-CFP-
TRP1 MYO1-mCherry::HIS3 mad2::KanMX ade2 
JRC379A-4d 
MATa bar1 CDH1-m11 GALL-HA-ACM1-LEU2::leu2 HT2B-mCherry-HIS5 MYO1-
GFP-KanMX 
JRC379A-1a 
MATa bar1 CDH1 GALL-HA-ACM1-LEU2::leu2 HT2B-mCherry-HIS5 MYO1-GFP-
KanMX 
JRC388A-5c 
MATa CDH1-11m HT2B-mCherry-HIS5 405-GALL-109 MYO1-mCherry::HIS3 
SPC29-YFP-HIS3  CFP-TUB1-TRP1 
JR90 MATa TRP1-18MYC-CDC20-WT ADE2 URA3::ura3 pRS313:GAL4-MR-HIS3 
JR91 
MATa TRP1-18MYC-CDC20-WT ADE2 GALL-HA-CDH1-WT-URA3::ura3 
pRS313:GAL4-MR-HIS3 
JRC142-8c MATa CDH1-3N 
JRC143-2b MATa CDH1-4N 
JRC144-9c MATa CDH1-7C 
JRC145-2a MATa CDH1-4C 
JRC146-4d MATa CDH1-WT 
JRC147-1c MATa CDH1-8C 
JRC148-5d MATa CDH1-1C 
JRC149B-8d MATa CDH1-2C 
2151-1C MATa cdh1::HIS3 
JRC397A-4a MATa GAL1-3FLAG-ACM1-URA3::ura3 
JRC177A-3d MAT? CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 
JRC113-4b MATa CDH1-4N GAL1-3FLAG-ACM1-URA3::ura3 
MNX32-6a MATa CDH1-7N GAL1-3FLAG-ACM1-URA3::ura3 
JRC115-3a MATa CDH1-9N GAL1-3FLAG-ACM1-URA3::ura3 
JRC116-6a MATa CDH1-10N GAL1-3FLAG-ACM1-URA3::ura3 
JRC117-1b MATa CDH1-11N GAL1-3FLAG-ACM1-URA3::ura3 
JRC180d-6d MAT? CDH1-1C GAL1-3FLAG-ACM1-URA3::ura3 
JRC182D-7b MAT? CDH1-2C GAL1-3FLAG-ACM1-URA3::ura3 
JRC179C-4b MAT? CDH1-4C GAL1-3FLAG-ACM1-URA3::ura3 
JRC181B-7c MATalpha CDH1-7C GAL1-3FLAG-ACM1-URA3::ura3 
JRC135-10b MATa CDH1-8C GAL1-3FLAG-ACM1-URA3::ura3 
JRC437A-6c MATa CDH1-4N GAL-3FLAG-ACM1-URA3::ura3 
JRC3437A-4d MATa CDH1-4N clb5::HIS3 GAL-3FLAG-ACM1-URA3::ura3 
JRC437A-9c MATa CDH1-4N clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC437A-6a MATA CDH1-4N clb5::HIS3 clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC439A-11d MATa CDH1-7C GAL-3FLAG-ACM1-URA3::ura3 
JRC439A-5d MATa CDH1-7C clb5::HIS3 GAL-3FLAG-ACM1-URA3::ura3 
JRC439A-5b MATa CDH1-7C clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC439A-3d MATa CDH1-7C clb5::HIS3 clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC436A-10a MATa CDH1 GAL-3FLAG-ACM1-URA3::ura3 
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JRC436A-6c MATa CDH1 clb5::HIS3 GAL-3FLAG-ACM1-URA3::ura3 
JRC436A-1c MATa CDH1 clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC436A-1d MATa CDH1 clb5::HIS3 clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC438A-4c MATa CDH1-8C GAL-3FLAG-ACM1-URA3::ura3 
JRC438A-1b MATa CDH1-8C clb5::HIS3 GAL-3FLAG-ACM1-URA3::ura3 
JRC438A-6c MATa CDH1-8C clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC438A-4a MATa CDH1-8C clb5::HIS3 clb6::KanMX GAL-3FLAG-ACM1-URA3::ura3 
JRC177A-3d MAT CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 
JRC177A-5c MAT CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC177A-7a MATalpha CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC177D-12b MATalpha CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC262A-2a MATa CDH1-T12A GAL1-3FLAG-ACM1-URA3::ura3 
JRC262A-1c MATa CDH1-T12A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC262A-9d MATa CDH1-T12A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC262A-9c MATa CDH1-T12A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC263A-9d MATa CDH1-S16A GAL1-3FLAG-ACM1-URA3::ura3 
JRC263A-2b MATa CDH1-S16A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC263A-5b MATa CDH1-S16A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC263A-3b MATa CDH1-S16A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC264A-3b MATa CDH1-S42A GAL1-3FLAG-ACM1-URA3::ura3 
JRC264A-2b MATa CDH1-S42A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC264A-2a MATa CDH1-S42A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC264A-1b MATa CDH1-S42A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC265A-8c MATa CDH1-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC265A-2b MATa CDH1-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC265A-7d MATa CDH1-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC265A-1c MATa CDH1-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC276A-3d MATa CDH1-T12A-S16A GAL1-3FLAG-ACM1-URA3::ura3 
JRC276A-12b MATa CDH1-T12A-S16A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC276A-8a MATa CDH1-T12A-S16A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC276A-9c 
MATa CDH1-T12A-S16A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC310A-10a MATa CDH1-T12A-S42A GAL1-3FLAG-ACM1-URA3::ura3 
JRC310B-3a MATa CDH1-T12A-S42A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX  
JRC310A-3a 
MATa CDH1-T12A-S42A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
acm1::KanMX  
JRC310A-3b MATa CDH1-T12A-S42A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3  
JRC398B-8c MATa CDH1-T12A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC398B-9b 
MATa CDH1-T12A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC398A-12d MATa CDH1-T12A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC398C-1b MATa CDH1-T12A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC311A-9d MATa CDH1-S16A-S42A GAL1-3FLAG-ACM1-URA3::ura3 
JRC311A-11d MATa CDH1-S16A-S42A acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
JRC311A-7c 
MATa CDH1-S16A-S42A msn5::HIS3 acm1::KanMX GAL1-3FLAG-ACM1-
URA3::ura3 
JRC311A-7d MATa CDH1-S16A-S42A msn5::HIS3 GAL1-3FLAG-ACM1-URA3::ura3 
JRC320A-6b MATalpha CDH1-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC320A-7a 
MATalpha CDH1-S16A-T157A acm1::KanMX msn5::HIS3 GAL1-3FLAG-ACM1-
URA3::ura3 
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JRC320A-1a MATalpha CDH1-S16A-T157A msn5::HIS3 GAL1-3FLAG-ACM1-URA3::ura3 
JRC320A-4d MATalpha CDH1-S16A-T157A acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
JRC267A-3d MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC267A-7b MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX  
JRC267A-10a MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC267A-4c 
MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC280A-1b MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC280A-6a MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC280B-7c MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC280B-5b 
MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC269B-2b MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC269B-1b MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX  
JRC269A-6c MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC269A-1a 
MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
MNX33-3c MATa CDH1-4N msn5null::HIS3 GAL1-3FLAG-ACM1-URA3::ura3 
MNX33-7d MATa CDH1-4N acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
MNX33-1d MATa CDH1-4N msn5null::HIS3 acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
JRC181D-5c MATa CDH1-7C GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC181C-1b MATalpha CDH1-7C GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC181D-3a MATalpha CDH1-7C GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC397A-9b MATa GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC397A-9a MATa GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC397A-1c MATa GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
JRC177A-7a MATalpha CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC177D-12b MATalpha CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC177A-5c MAT CDH1-3N GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX msn5::HIS3 
MNX31-6c MATa CDH1-8c msn5::HIS3 GAL1-3FLAG-ACM1-URA3::ura3 
MNX31-6d MATa CDH1-8c msn5::HIS3 acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
MNX34-11c MATa CDH1-8c acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 
JRC135-10b MATa CDH1-8C GAL1-3FLAG-ACM1-URA3::ura3 
JRC267A-3d MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC267A-7b MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX  
JRC267A-10a MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC267A-4c 
MATa CDH1-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC280A-1b MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC280A-6a MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC280B-7c MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
JRC280B-5b 
MATa CDH1-T12A-S16A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC268B-3c MATa CDH1-T12A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC255A-3c  CDH1-T12A-S42A-T157A acm1::KanMX GAL1-3FLAG-ACM1-URA3::ura3 ade2 
JRC268A-10d MATa CDH1-T12A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC268A-10b 
MATa CDH1-T12A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JRC269B-2b MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 
JRC269B-1b MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX  
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JRC269A-6c MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 msn5::HIS3 
JRC269A-1a 
MATa CDH1-S16A-S42A-T157A GAL1-3FLAG-ACM1-URA3::ura3 acm1::KanMX 
msn5::HIS3 
JR13 MATa HIS3::GFP-TUB1 MYO1-GFP-KANMX bar1 MYC-CDC20-TRP1 ADE2 
JR52 MATa HIS3::GFP-TUB1 MYO1-GFP-KAN bar1 TRP1-18MYC-CDC20-db1 ADE2 
JR55 MATa HIS3::GFP-TUB1 MYO1-GFP-KANMX bar1 MYC-CDC20-db2-TRP1 ADE2 





Plasmid Name Description Plasmid Notes 
FC695 pRS406 cdh1-m11::TRP1 cut with BglII to integrate at CDH1 
FC697 pRS406 cdh1-m11::LEU2 cut with BglII to integrate at CDH1 
JRP67 pRS406 CDH1-pkm (S125A-S259A) cut with BglII to integrate at CDH1 
JRP90 
pRS406 CDH1-pbm (S15A-S41A-S156A-
S172A) cut with BglII to integrate at CDH1 
406-HLP112 pRS406 GAL1-3FLAG-ACM1 cut with StuI to integrate at ura3 
405-GALL-HLP109 pRS405 GALL-HA-ACM1 cut with XcmI to integrate at leu2 
DJC235 18MYC-CDC20-TRP1 cut with MluI integrate at CDC20 
JRP87 pRS406 6MYC-CIN8 cut with PacI to integrate at CIN8 
JRP88 pRS406 6MYC-CIN8 alaKEN cut with PacI to integrate at CIN8 
JRP89 pRS406 6MYC-CIN8-KED cut with PacI to integrate at CIN8 
JRP91 pRS406 ACM1 cut with StuI to integrate at ura3 
JRP95 pRS406 MET3-CLB2-ken,db cut with StuI to integrate at ura3 
DJC235 pRS404 18MYC-CDC20 MluI to integrate at CDC20 
JRP1 18MYC-CDC20-db1-TRP1 MluI to integrate at CDC20 
JRP2 18MYC-CDC20-db2-TRP1 MluI to integrate at CDC20 
JRP3 18MYC-CDC20-db3-TRP1 MluI to integrate at CDC20 
FC681 pRS406 CDH1 cut with BglII to integrate at CDH1 
FC687 pRS406 CDH1-m11 cut with BglII to integrate at CDH1 
FC801 pRS406 cdh1::TRP1 cut with BglII to integrate at CDH1 
JRP4 pRS406 cdh1::LEU2 cut with BglII to integrate at CDH1 
JRP5 pRS406 GALL-HA-CDH1 cut with BglII to integrate at CDH1 
JRP6 pRS406 GALL-HA-CDH1-m11 cut with BglII to integrate at CDH1 
JRP55 pRS406 CDH1-T12A cut with BglII to integrate at CDH1 
JRP56 pRS406 CDH1-S16A cut with BglII to integrate at CDH1 
JRP57 pRS406 CDH1-T42A cut with BglII to integrate at CDH1 
JRP58 pRS406 CDH1-T12A T42A cut with BglII to integrate at CDH1 
JRP59 pRS406 CDH1-S16A T42A cut with BglII to integrate at CDH1 
JRP60 pRS406 CDH1-T12A-T157A cut with BglII to integrate at CDH1 
JRP62 pRS406 CDH1-T42A-T157A cut with BglII to integrate at CDH1 
JRP63 pRS406 CDH1-T12A-T42A-T157A cut with BglII to integrate at CDH1 
JRP64 pRS406 CDH1-S16A-T42A-T157A cut with BglII to integrate at CDH1 
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